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1. INTRODUCTION 
MEDICINAL HERBS  
Herbal medicine is the oldest form of health care system known to 
mankind and all living being including man has been troubling by many 
aliments from past so many centuries and most often nature has provided 
the cure. Herbs had been used by all cultures throughout history and are the 
important members of nature. Herbs  has played the great role from years in 
combating the disease of human race. 
Herbal medicine is a major component in all indigenous people’s 
traditional medicine. In India the use of the medicinal herbs is as old as 
1500BC. Medicinal herbs have been in use for thousands of years, in one 
form or other, under the indigenous system of medicine like Ayurveda, Unani 
and Sidha. India has 13,000-20,000 specious flowering plants, 2800 algae, 
23,000 fungi, 1,600 types of latches, 1,800 varieties of bryophytes and an 
estimated 30 million types of microorganisms. There are few medicinal herbs 
of commercial importance, in context with the abundant flora in India. India is 
perhaps the large producer of medicinal herbs and is rightly called as 
“Botanical garden of the world”. Herbal medicines are prepared from a 
variety of plant material such as leaves, stems, roots, barks, etc. They 
usually contain many biologically active ingredients and are considered to be 
medicinal if they possess pharmacological activities of possible therapeutic 
use. Today, herbal drugs are coming back into prominence and many drugs 
commonly used today care  of herbal origin. Indeed, about 25 percent of the 
prescription drugs dispensed in the United States of America contain at least 
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one active ingredient derived from plant materials. Side effects of the 
conventional medicines such as antibiotics, antimicrobial agents are the 
major problem. Over the years, some of the infectious organisms have 
developed resistance to synthetic drugs hence more and more 
complications. Demand for medicinal plant is increasing in both developing 
and developed countries due to growing recognition of natural product 
having no side-effects, easily available at affordable prices and sometime 
the only source of health care available to the poor people.  
Herbals are used in the art of healing since the time immemorial and 
the primitive man through trial and error gained knowledge of herbal and 
passed this information on to the next progeny. Despite the development in 
modern medicines, the use of herbs is still increasing. As the time went on, 
each tribe added the medicinal power of herbs in the area to its knowledge 
base. They methodically collected information on herbs that help in the 
development of well-defined herbal pharmacopoeias. Some of those in the 
current use have been an ancient heritage, whereas other has arisen from 
discoveries and cultural trends in more recent centuries.  
According to the World Health Organization (WHO) more than 1 billion 
people rely to some extent on medicinal. The WHO has listed 22,000 plants 
around the world having medicinal values. The extensive advances and 
development of science of phyto-pharmaceuticals and hopes for remedies in 
chronic disease generated new enthusiasm in the research workers to 
develop herbal medicines. The major achievement in the field was the 
discovery of vincristine and vinblastine in the madagascars periwinkle and it 
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make marked difference in the treatment of cancer. Morphine, digitoxin, 
ergotamine and quinine are the some of the other excellent drugs that 
obtained from different plant species (Tyler et al.1998) 
LIVER-INTRODUCTION           
The liver has pivotal rule in human metabolism, including 
detoxification, protein synthesis, and the production of bio-chemicals 
necessary for digestion. The liver is necessary for survival; there is no 
currently way to compensate for the absence of liver function long term, 
however liver cell can regenerate.  
It produces and secretes bile that stored in gallbladder which used to 
break down and digest fatty acids in food. 
 It also produces prothrombin and fibrinogen, both are blood-clotting 
factors. 
 It converts sugar into glycogen, which it stores until the muscle cells 
need energy and it is secreted into the blood stream as glucose. 
 It synthesizes protein and cholesterol and convert carbohydrates and 
protein into fats, which is stored for later uses. 
 It also produces blood protein and enzymes needed for digestion and 
other bodily functions in body. 
 The liver stores critical trace elements such as iron, copper, as well as 
vitamins A, D, and B12. 
 The liver is responsible for detoxifying of poisonous substances in the 
body. 
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One of the primary functions of the liver is to aid in the metabolism of 
substance including food, dietary supplement, alcohol, and other 
medications, Due to its unique metabolism and closely related with the 
gastrointestinal tract, the liver is susceptible to injury from drugs and other 
substances. 75% of blood coming to the liver arrives directly from the 
gastrointestinal organs and then spleen via portal veins which bring drugs 
and xenobiotics in near-undiluted form and there several mechanisms are 
responsible for either inducing hepatic injury or worsening the damage 
process. Many chemicals damages mitochondria, an intracellular organelle 
that produce energy. Its dysfunction release excessive amount of oxidants 
which, in turn, injured the hepatic cells. Activation of some enzymes in the 
cytochrome P-450 system such as CYP2E1 also lead to the oxidative stress. 
In fact, there are many types of liver disease that can be caused by virus, 
damage from drugs or chemicals, obesity, diabetes or an attack from your 
own immune system. 
According to W.H.O about 25,000 people die in every year due to 
hepatic diseases. The common ailments of liver are cirrhosis, cholestasis, 
hepatitis, hepatic encephalopathy, portal hypertension, fulminate hepatic 
failure and certain tumors like hepatoma in liver. It is estimated that 2 billions 
people around the world are infected with hepatitis B virus about 370 millions 
of these have the chronic form of the disease. 
Medicinal herbs are significant source of pharmaceutical drug and the 
latest trends have shown increasing demand of phytodrugs and some 
medicinal herbs have been proven hepatoprotective potential. Silymarin, a 
flavonol lignin mixture extracted from silybum marianum (milk thistle) is a 
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popular remedy for hepatic diseases. The present study is an attempt to test 
the hepatoprotective activity of Solanum seaforthianum leaf extract. 
Anatomy of Liver.                                                                                             
The liver has a right lobe and a left lobe and inside the two lobes is a 
network of tubes, also called the biliary tree which carries bile from liver to 
intestine. The liver lies to the right of the stomach and overlies 
the gallbladder and it is connected to two large blood vessels, one called the 
hepatic artery and one called the portal vein. The hepatic artery carries 
blood from the aorta, whereas the portal vein carries blood containing 
digested nutrients materials from the entire gastrointestinal tract and also 
from the spleen and pancreas. These blood vessels subdivide into 
capillaries and which then lead to a lobule. Each lobule is made up of 
millions of hepatic cells which are the basic metabolic cells and that are the 
functional units of the liver. 
 
Figure 1.  Anatomy of liver 
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Histology of liver 
The basic functional unit of liver is the liver lobule, a cylindrical 
structure, several millimeters in length 0.8 mm. and 2 mm in diameter. The 
human liver contains 50,000 to 1, 00,000 lobules and which is constructed 
around a central vein which empties into a hepatic venule than the hepatic 
vein finally into inferior venacava. The hepatic lobule is roughly a hexagonal 
arrangement of plates of hepatocytes radiating outward from a central vein 
in the center in liver. 
The hepatic acinus which is oriented around the afferent vascular 
represents a unit that is consists of an irregular shaped. Roughly ellipsoidal 
mass of hepatocytes aligned around the hepatic arterioles and portal 
venules. The acinus is roughly divided into zones that correspond to 
distance from the arterial blood supply those hepatocytes closest to the 
arterioles are the best oxygenated, while those farthest from the arterioles 
have the poorest oxygen supply. 
Hepatocytes are the major functional cells of the liver and are 
polygonal in shape. Hepatic cells sides can be in contact either with 
sinusoids (sinusoidal face) or neighboring hepatocytes (lateral faces) the mid 
perform a number of metabolic endocrine and secretory functions. Roughly 
80% of the mass of the liver is contributed by hepatocytes and are 
exceptionally active in synthesis of protein and lipids for export and also 
synthesize and secrete very low density lipoproteins. 
Another type of particle observed in copious quantities in liver is 
glycogen. It is a polymer or glucose and the density or its aggregates in 
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hepatocytes varies dramatically depend on whether the liver is examined 
shortly after the meal (abundant glycogen) or following a prolonged fast 
(minimal quantities of glycogen). 
     Sinusoids are the canals formed by the plates of hepatocytes. 
They are approximately 8-10 ¹m in diameter and comparable with the 
diameter of normal capillaries. They are orientated in a radial direction in the 
lobule. Sinusoids are low-pressure vascular channels that receive blood 
from terminal branches of the hepatic artery and portal vein at the periphery 
of lobules and deliver it into central veins. Sinusoids are lined with 
endothelial cells and flanked by plates of hepatocytes. The space between 
sinusoidal endothelium and hepatocytes is called the space of Disse. 
Sinusoidal endothelial cells are highly fenestrated, which allows virtually' 
unimpeded flow of plasma from sinusoidal blood into the space of Disse. 
Functions of the liver 
 
Figure 2. Functions of the liver 
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 Carbohydrate metabolism 
 Glugconeogenesis 
 Glycogen synthesis & metabolism 
 The liver is especially important in maintaining a normal blood 
glucose level in body and can break down glycogen to glucose and 
release glucose into the bloodstream when blood  have low glucose 
level. The liver also can convert amino acids into lactic acid and 
galactose into glucose. The liver converts glucose to glycogen and 
triglycerides for storage when blood glucose is high, as occurs just after 
having a meal. 
 Lipid metabolism 
 Fatty acid synthesis 
 Cholesterol synthesis &excretion 
 Lipoprotein synthesis. 
 Ketogensis.(converting) The fatty acid ketone bodies. 
 Hepatocytes store some triglycerides, break down fatty acids to 
generate ATP, synthesize lipoproteins, transport fatty acids, triglycerides and 
cholesterol to and from the body cells, synthesize and use cholesterol to 
make bile salts. 
 Protein metabolism 
 Synthesis of plasma proteins. 
 Urea synthesis. 
 Hepatocytes de-aminate (remove the amino group, NH2) amino acids 
so that amino acid can be used for the production ATP or converted to 
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carbohydrate or fats. The resulting toxic ammonia is   which is then 
converted into the much less toxic urea and excreted in urine. Hepatocytes 
can also synthesize most plasma proteins, such as alpha and beta globulins, 
albumin, prothrombin and fibrinogen. 
 Processing of drugs and hormones: 
 Metabolism , conjugation & excretion of steroidal & poly peptide 
hormones 
 The liver can detoxify substances such as alcohol or excrete drugs 
like penicillin, erythromycin, and sulfonamides into the bile. It can also 
chemically alter or excrete thyroid hormones and steroid hormones such as 
estrogen arid aldosterone. 
 Excretion of Bilirubin: 
Bilirubin, derived from the blood cells is absorbed by the liver from the blood 
steam and secreted into bile. Most of the bilirubin in bile is metabolized in 
the small intestine by bacteria and eliminate in to feces. 
 Phagocytosis: 
 The stellate reticulo-endothelial (Kupffer's) cells of the liver 
phagocytose aged white blood cells,red blood cellsand some bacteria.  
 Storage 
Liver is a good part in storage of glycogen,vitamin A,vitamin B12 and 
iron 
LIVER DISEASES  
Liver diseases are considered as fatal & life threatening and it creates 
a serious challenge to public health. Liver diseases are due to infection and / 
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or exposure of liver to various toxic substances such as different drugs or 
alcohol. Some times over dosage of some drugs can also lead to liver 
damage. Now-a-day’sdue to inadequacy of liver protective agents, 
researchers and traditional medicine practioners are concentrate in herbal 
based remedies for the various liver disorders. Modern medicines have little 
to offer for alleviation of hepatic disorders so there was no safe 
hepatoprotective drug available for the treatment of liver disorders. 
Therefore, many folk remedies from plantsource are used for the protection 
of hepatic disease starting from ancient period. Liver diseases remain as 
one of the serious health problems however we do not have satisfactory liver 
protective drugs in allopathic medical practice so herbal drugs play a role in 
the management of various liver disorders most of which speed upthe 
natural healing processes. Numerous medicinal plants and their formulations 
are used for liver disorders in ethnomedical practices as well as traditional 
system of medicine in India.  
Liver disease which cause an acute or chronic damage to the liver, 
usually caused by infection, injury, exposure to many drugs or toxic 
compounds, an autoimmune process, or by a genetic defect such as 
haemochromatosis. The disease can also be categorized according to the 
effect it has on the liver. Hepatitis is an inflammation of the liver, cirrhosis 
involves scarring and progressive hepatic cell death, stones can be 
developed and which form blockages, fatty liver and cancer, which can be 
life threatening. Genetic defect cause liver disease by preventing vital 
functions or by depositing substances the liver cell. 
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 HEPATITIS: 
There are two major forms of hepatitis 
One in which the liver is damaged quickly (called as acute hepatitis) 
and the other in which the liver is damaged slowly only, over a long time 
(called as chronic hepatitis). 
While hepatitis can be caused by any of the means mentioned above, 
most commonly it is due to infection by several viruses that damage the 
liver, termed hepatitis viruses.  These Viruses have been named in the 
according to their discovery as hepatitis A, B, C, D, and E. 
 Hepatitis A 
This infection is usually caused by consuming contaminated water or 
food and is especially common in children. Most infected people do not even 
know about they have been exposed to the virus. 
 Hepatitis B 
It is fairly common disease and still the most common cause of acute 
viral hepatitis. Hepatitis B can spread one person to other by exposure to 
blood, through sexual relations, and from mother to baby. In a small number 
of cases, Hepatitis B can develop into a chronic infection and vaccine to 
prevent infection is available. 
 Hepatitis C 
It is less common than hepatitis B as a cause of acute hepatitis, but in 
some cases the majority of the people who contract it become chronically 
infected, hepatitis c can able to spread through contact with infected blood, 
Hepatitis C infection can be very serious. Most people infected experience 
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no symptoms but the virus may remain in the liver for years and it is not 
discovered until much damage is done. Up to fifty percent of those infected 
with Hepatitis C are able to fight off the virus within six months. However, 
many patients become develop a chronic infection. 
Hepatitis D and E are rare. 
 CIRRHOSIS 
Anything that causes severe ongoing injury to the hepatic cells can 
lead to cirrhosis. It is marked by cell death or scar formation and which lead 
to a progressive disease that creates irreversible damage of liver. Cirrhosis 
is treated by trying to limit further damage to liver and the main causes of 
cirrhosis include chromic excessive alcohol intake; auto immune diseases, it 
can be cause fluid build-up in the abdomen called as cites, muscle wasting, 
bleeding from the intestines easy bruising, enlargement of the breasts in 
men called as gynecomiastia, and a number of other problems may be 
occur.  
 GALLSTONES 
Cholesterol and bile pigments (bilirubin) in the bile may form stone in 
the gallbladder. If present for a long time, they may damage the gall bladder 
and may block the duct that origins bile from the gallbladder which causing 
sharp pain to develop suddenly in the upper right pan of the abdomen, and 
in some cases, leading of the gallbladder and fever. 
 OBSTRUCTION 
Gallstones, trauma, tumors, and inflammation can cause blockage or 
obstructions in the ducts draining the liver .When an obstruction occurs, bile 
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and its associated wastes accumulate in the liver cells and the patient's skin 
and eyes often turn to yellow (Jaundice) bilirubin in the urine turns to dark 
brown in color. 
 FATTY LIVER 
 Fatty liver which causes liver enlargement, tenderness, and abnormal 
liver functions and the common cause is excessive alcohol consumption. It is 
usually a reversible condition, resolving with abstention from alcohol. 
Another cause of fatty liver is NASH (Non Alcoholic Steato Hepatitis) the 
most common chronic hepatitis is not caused by viruses. It is seen 
commonly in overweight and diabetic individuals. Excess liver fat can lead to 
inflammation, progressing to scarring (or cirrhosis) in 25 percent of patients. 
Treatment includes weight loss, exercise, regulating blood pressure, 
diabetes control and cholesterol, limiting alcohol consumption and not 
smoking. 
 LIVER CANCER 
Hepatitis and cirrhosis may leads to liver cancer in some cases only, 
but cancer from other parts of the body that spreads to the liver is more 
common cause of liver cancer. It is better people who have chronic hepatitis 
or cirrhosis may be checked on a regular basis for cancer, often with an 
Alpha-Fetoproteins (AFP) test or an ultrasound. Infiltrative conditions which 
can be affect the liver include lymphomas and amyloidosis. 
 INHERITED ABNORMALITIES IN  METABOLISM 
 
 There are four conditions in which jaundice is caused by inherited 
abnormality of Bilirubin metabolism are gilberts,crigler – najjar , Dubin – 
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Johnson& rotor syndromes.Gilbert’s syndrome affects 2-3% of the 
population but the others are rare and the patient With Gilberts syndrome 
decreased conjugation of blood.  The jaundice of Gilbert’s syndrome is 
typically mild & present only intermittently. It is often noticed after an 
infection or a period of deceased of food intake. The liver will be 
histologically normal. 
 
 Wilsons disease is an Inherited abnormality of copper metabolism in 
liver and characterized by decreased biliary excretion of copper. Copper is 
deposited in the liver and patientswithWilsons diseases may present either 
in child hood with hepatitis accompanied by haemolysis & renal tubular 
defect or in young with cirrhosis may be happen. 
 
Hereditary Hemochromatosis – The common adult genetic liver 
disease in which a specific genetic defect lead to iron accumulation in the 
liver cells, leading to liver cancer and liver cirrhosis in some patients. 
Ironaccumulation may go beyond the liver affecting the joints, heart and 
pancreas. Specific effective treatments are available for Hemochromatosis. 
Liver transplantation may be required in some of these patients. 
 
 Alpha-1 antitrypsin deficiency (Alpha-1) – This inherited disease 
affect the liver and the lungs in patient. which is caused by an inability to 
produce enough amount of a particular protein, called Alpha-1 antitrypsin, 
which is used to prevent the breakdown of  some enzymes in various 
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organs. Management of Alpha-1 antitrypsin deficiency includes maintaining 
normal nutrition,patient education. 
 
HEPATOTOXICITY 
Toxic liver injury produced by some drugs and chemicals may virtually 
mimic any form of naturally occurring liver disease. Severity of hepatotoxicity 
is greatly increased if the drug is continued after symptoms develop. 
  Arsenic, copper, phosphorus and iron are among the various 
inorganic compounds producing hepatotoxity. The organic agents include 
certain naturally- occurring plant toxins such as pyrrolizidine, mycotoxins, 
alkaloids and bacterial toxins. In addition, exposure to hepatotoxin 
compounds may environmental, occupational or domestic that could be 
accidental, homicidal or suicidal ingestion. 
MECHANISM OF HEPATOTOXICITY CAUSED BY DIFFERENT AGENTS 
Damage to the liver is not due to the drug itself but due to a toxic 
metabolite N-acetyl-p benzoquinonimne (NABQI/NAPQI) which is produced 
by cytochrome P 450 enzymes in liver. 
In overdoses large amount of NAPQI is generated which overwhelm 
the detoxification process and lead to damage to hepatic cells. Nitric acid 
also plays some role in inducing toxicity. Hepatotoxicity caused by NSAIDs 
were documented to be both idiosyncratic and dose dependant eg; Aspirin 
and phenylbutazone are associated with intrinsic hepatotoxicity and 
idiosyncratic reaction has been associated with ibuprofen, sulindac, 
phenylbutazone, piroxicam, diclofenac and indomethacin. Enlarged liver 
cells is a rare side effect of long term use of steroid in children. 
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Carbon tetrachloride 
Liver injury due to carbon tetrachloride in rats was first reported in 
1936 and has been widely and successfully used by many investigators. 
Carbon tetrachloride is metabolized by cytochrome P 450 in endoplasmic 
reticulum and mitochondria with the formation of CC13O
-, a reactive 
oxidative free radical, which initiates lipid peroxidation. 
                                          CCl4 ------------ ► CClO3- + O- 
 It is postulated that secondary mechanisms link carbon tetrachloride 
metabolism to the widespread disturbances in hepatocyte function. These 
secondary mechanisms could involve the generation of toxic products 
arising directly from carbon tetrachloride metabolism or from peroxidative 
degeneration of membrane lipids. The possible involvement of radical 
species such as trichloromethyl (·CCl3), trichloromethylperoxy (·OOCCl3), 
and chlorine (·Cl) free radicals, as well as phosgene and aldehydic products 
of lipid peroxidation, as toxic intermediates 
Administration of a single dose of CC14 to a rat produces, within 24 
hrs, a centrilobular necrosis and fatty changes. The poison reaches its 
maximum concentration in the liver within 3 hrs of administration. Thereafter, 
the level falls and by 24 hrs there is no CCl4 left in the liver. The 
development of necrosis is associated with leakage of hepatic enzymes into 
serum. 
Dose of CCl4: 0.1 to 3 ml/kg I.P. 
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Galactosamine 
Galactosamine produces diffuse type of liver injury simulating viral 
hepatitis. It presumably disrupts the synthesis of essential uridylate 
nucleotides resulting in organelle injury and ultimately cell death. Depletion 
of those nucleotides would impede the normal synthesis of RNA and 
consequently would produce a decline in protein synthesis. The cholestasis 
caused by galactosamine may be from its damaging effects on bile ducts or 
ductless or canalicular membrane of hepatocytes. Galactosamine decrease 
the bile flow and its content i.e. bile salts, cholic acid and deoxycholic acid. 
Galactosamine reduces the number of viable hepatocytes as well as rate of 
oxygen consumption. 
Dose of D-Galactosamine: 400 mg/kg, P. 
 
Thioacetamide 
Thioacetamide interferes with the movement of RNA from the nucleus 
to cytoplasm which may cause membrane injury. A metabolite of 
thioacetamide (perhaps s-oxide) is responsible for hepatic injury. 
Thioacetamide reduce the number of viable hepatocytes as well as rate of 
oxygen consumption. It also decreases the volume of bile and its content i.e. 
bile salts, cholic acid and deoxycholic acid. 
Dose of Thioacetamide: 100 mg/kg, S.C. 
Alcohol 
The effects of ethanol have been suggested to be a result of the 
enhanced generation of oxyfree radicals during its oxidation in liver. The 
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peroxidation of membrane lipids results in loss of membrane structure and 
integrity. This results in elevated levels of i-glutamyltranspeptidase, a 
membrane bound enzyme in serum. Ethanol inhibits glutathione peroxidase, 
decrease the activity of catalase, superoxide dismutase, along with increase 
in levels of glutathione in liver. The decrease in activity of antioxidant 
enzymes superoxide dismutase, glutathione peroxidase are speculated to be 
due to the damaging effects of free radicals produced following ethanol 
exposure or alternatively could be due to a direct effect of acetaldehyde, 
formed by oxidation of ethanol. Alcohol pre-treatment stimulates the toxicity 
of CCl4 due to increased production of toxic reactive metabolites of CCl4, 
namely trichloro-methyl radical by the microsomal mixed function oxidative 
system. This lipid peroxidative degradation of bio membranes is the principle 
cause of hepatotoxity. 
 
Paracetamol 
Paracetamol, a widely used analgesic and antipyretic drug,Damage to 
the liver is not due to the drug itself but to a toxic metabolite (N-acetyl-p-
benzoquinone imine NAPQI, or NABQI) which is produced by cytochrome P-
450 enzymes in the liver. In normal circumstances, this metabolite is 
detoxified by conjugating with glutathione in phase 2 reaction. In an 
overdose, a large amount of NAPQI is generated which overwhelms the 
detoxification process and leads to necrosis of the centrilobular hepatocytes 
characterized by nuclear pyknosis and eosinophilic cytoplasm followed by 
large excessive hepatic lesion. 
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Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 
Although individual analgesics rarely induce liver damage due to their 
widespread use, NSAIDs have emerged as a major group of drugs exhibiting 
hepatotoxicity. Both dose-dependent and idiosyncratic reactions have been 
documented. Aspirin and phenylbutazone are associated with intrinsic 
hepatotoxicity; idiosyncratic reaction has been associated with ibuprofen, 
sulindac, phenylbutazone, piroxicam, diclofenac and indomethacin. 
 
Glucocorticoids 
Glucocorticoids are so named due to their effect on the carbohydrate 
mechanism. They promote glycogen storage in the liver. An enlarged liver is a 
rare side effect of long-term steroid use in children. The classical effect of 
prolonged use both in adult and paediatric population is steatosis. 
 
Isoniazid 
Isoniazide (INH) is one of the most commonly used drugs for 
tuberculosis; it is associated with mild elevation of liver enzymes in up to 20% of 
patients and severe hepatotoxicity in 1-2% of patients. 
 
Natural products 
Examples include many amanita mushrooms (particularly the 
destroying angels), and aflatoxins 
 
SCREENING MODELS 
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In vivo models. 
A toxic or repeated doses of a known hepatotoxin (carbon 
tetrachloride, paracetamol, thioacetamide, alcohol, D-galactosamine etc.) 
might be administered, to induce liver damage in experimental animals. The 
test substance (plant extract) is administered along with, prior to and/or after 
the toxin treatment. Assessment of liver damage and recovery from damage 
are by quantifying serum marker enzymes, bilirubin, bile flow, 
histopathological changes and biochemical changes in liver. An augmented 
level of liver marker enzymes such as serum glutamate pyruvate 
transaminase, serum glutamate oxaloacetate transaminase and alkaline 
phosphatise in the serum indicates liver damage. Additionally, hepatotoxicity 
may result in decline of prothrombin synthesis giving an extended 
prothrombin time and reduction in clearance of certain substances such as 
bromsulphthalein may be used in the assessment of hepatoprotective action 
of plants. Efficacy in therapy of a drug against diverse hepatotoxins differs 
especially when their mechanism of action vary. Consequently, the efficacy 
of each drug has to be tested against hepatotoxins which act by varied 
methods. Hepatotoxic chemicals like carbon tetrachloride, paracetamol 
reduces the level of metabolizing enzymes in liver. For the above reason, 
metabolism of hexabarbitone is reduced resulting in prolongation of hexa-
barbitone induced sleeping time. Hence, reduction in carbon tetrachloride -
induced prolongation of hexobarbitone stimulated sleeping time may be 
exploited to screen anti-carbon tetrachloride toxicity of drugs in animals. 
Care has to be taken to see that the drug has no direct effect on drug 
metabolizing enzymes or necrosis. 
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In vitro studies 
Fresh hepatocyte preparations and primary cultured hepatocytes may 
be exploited to study the anti-hepatotoxic activity of drugs. Hepatocytes are 
treated with hepatotoxin and the effect of the plant drug on the same is 
evaluated. The activities of the transaminases released into the medium are 
determined. An augmented activity of marker transaminases in the medium 
indicates liver damage. Parameters such as hepatocytes multiplication, 
morphology, macromolecular synthesis and oxygen consumption are 
determined. Effective antiviral assays using cell culture and Polymerase 
Chain Reaction techniques remain to be explored and these may emerge as 
a very promising strategy for in vitro examination of hepatoprotective effect 
of herbal products.(Varshakashaw et al., 2011) 
 
LIVER FUNCTION TESTS 
As the liver performs it’s various functions and it makes chemicals 
that pass into the bloodstream and bile. Some of these chemicals can be 
measured in a blood sample and tests that are commonly done on a blood 
sample are called liver function tests (LFTs). These usually measure the 
following: 
The various uses of Liver function tests include: 
Screening: liver function test are a non-invasive yet 
sensitivescreening modality for liver dysfunctions. 
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Pattern of disease: liver function test are helpful to recognize the 
pattern of liver disease also helpful in differentiating between various 
disease such as acute viral hepatitis, cholestatic disorders and chronic liver 
disease. (CLD). 
 
Assess severity: liver function test are helpful to assess the severity 
and predict the outcome of certain diseases like primary biliary cirrhosis. 
 
Follow up: liver function test are helpful in the follow up of certain 
liver diseases and also helpful in evaluating response to therapy like 
autoimmune hepatitis. 
CLASSIFICATION OF LIVER FUNCTION TESTS 
A. Tests of the liver’s capacity to transport organicanions and to 
metabolize drugs-  
Serum bilirubin, urinebilirubin, urobilinogen etc… 
B. Tests that detect injury to hepatocytes (serum enzymetests) – 
Aminotransferases, alkaline phosphatase, ãglutamyl transpeptidase, 5-
nucleotidase, leucineaminopeptidase etc…. 
C. Tests of the Liver’s biosynthetic capacity-  
Serumproteins, albumin, prealbumin, serum ceruloplasmin,procollagen III 
peptide, antitrypsin,  feto protein,prothrombin time etc… 
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SERUM BILIRUBIN 
Bilirubin is an endogenous anion which derived fromhaemoglobin 
degradation from the RBC.Measuring bilirubin by direct and indirect bilirubin 
are based on the original van der Bergh method. Bilirubin is altered when 
exposure to light soserum and plasma samples must be kept in dark before 
measurements are made. When the liver function testsare abnormal and the 
serum bilirubin levels more than17μmol/L suggest underlying some liver 
disease. (Friedman SF et.al. 2003) 
 
Types of bilirubin 
i. Total bilirubin: This is measured as the amount, which reacts in 30 
minutes after addition of alcohol. Normal range is 0.2-0.9 mg/dl (2-15μmol/L) 
and it is slightly higher by 3-4 μmol/L in males as compared to 
females.Which helps to diagnose Gilbert syndrome inmales easily. 
ii. Direct Bilirubin: This is the water-soluble fraction. Direct bilirubin is 
measured by the reaction with diazotizedsulfanilic acid in 1 minute and it 
gives estimation of conjugated bilirubin. Normal range 0.3mg/dl (5.1μmol/L) 
iii. Indirect bilirubin: This fraction is calculated by the difference of the total 
and direct bilirubin and is a measure of unconjugated fraction of bilirubin. 
(Daniel SP, Marshall MK.1999) 
The elevated level of bilirubin which shows the decrease the hepatic 
clearance, the mild elevation due to liver disease physiological jaundice, 
inherited hyperbilirubinemias and moderate elevation due to drugs, viral 
hepatitis,inherited hyperbilirubinemias, Indiazo method of bilirubin estimation 
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is not very accurate especially in detecting low levels of bilirubin.Direct 
bilirubin over estimates bilirubin esters at low bilirubin levels and under 
estimates them at highconcentration. Thus slight elevation of unconjugated 
bilirubin not detected, which is of value in detectingconditions like Gilbert 
syndrome. (Rosalki SB et.al 1999) 
A. ENZYMES THAT DETECT HEPATOCELLULARNECROSIS – 
AMINOTRANSFERASES 
The aminotransferases (formerly transaminases) are specific 
indicators of hepatocellular necrosis. These enzymes- aspartate amino 
transferase (AST, formerly serum glutamateoxaloacetic transaminase-
SGOT) and alanine aminotransferase (ALT, formerly serum glutamic 
pyruvatetransaminase-SGPT) catalyze the transfer of the aminoacids of 
aspartate and alanine respectively to the á ketogroup of ketoglutaric acid. 
ALT is primarily localized tothe liver but the AST is present in a wide variety 
of tissueslike the heart, kidney, skeletal muscle, brain and liver. (Rosen HR, 
Keefe EB 2000). 
Alanine transaminase (ALT): This is an enzyme that helps to process 
proteins. (An enzyme is a protein that helps to speed up chemical reactions) 
Large amounts of ALT occur in liver cells but when the liver is injured or 
inflamed (as in hepatitis), the blood level of ALT usually rises and elevated 
level in ALT which shows leakage from damaged tissue  
Aspartate aminotransferase (AST): This is another enzyme usually found 
inside liver cells. When a blood test detects high levels of this enzyme in the 
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blood it usually means the liver is injured in some way. However AST can 
also be released if heart or skeletal muscle is damaged 
Alkaline phosphatase (ALP):. 
Average values of alkaline phosphatase may be vary with ageand are 
relatively high in childhood and puberty and lower in middle age and higher 
again in old age. Males usually have higher values when compared to 
females. The levels of the enzyme correlate with person’s weight and 
inversely with the height of the person, (Gordon T 1993). The mechanism by 
which alkaline phosphatise reaches the circulation is uncertain; leakage from 
the bile canaliculi into hepatic sinusoids may result from leaky tight junctions, 
(Kaplan MM 1986), and the other hypothesis is that thedamaged liver fails to 
excrete alkaline phosphatase made in bone, intestine and liver. In acute viral 
hepatitis level of alkaline phosphatase is usuallyeither normal or moderately 
increased. Hepatitis A maypresent a cholestatic picture with marked and 
prolongeditching and elevation of alkaline phosphatase. Tumours may 
secrete alkaline phosphatase into plasma and thereare tumour specific 
isoenzymes such as Regan, Nagao and Kasahara isoenzymes. Elevated 
serum levels of intestinal alkalinephosphatase have been found in patients 
with cirrhosis,particularly those with blood group type O, and may 
beassociated specifically with intra hepatic disease asopposed to 
extrahepatic obstruction. (Warnes TW 1977). 
Hepatic and bony metastasis can also cause elevated levels of 
alkaline phosphatase. Other diseases like infiltrative liver diseases, 
granulomatous liver disease, abscesses, and amyloidosis may also cause a 
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rise in alkalinephosphatase. Mildly elevated levels of alkaline phosphatase 
may seen in cirrhosis and hepatitis of congestive cardiac failure. Low levels 
of alkaline phosphatase occur in hypothyroidism, pernicious anemia, zinc 
deficiency and congenital hypophosphatasia. 
Albumin: This is the main protein made by the liver, and it circulates in the 
bloodstream. The ability to make albumin (and other proteins) is affected in 
some types of liver disorder. Corticosteroids and thyroid hormone stimulates 
albumin synthesis. A low level of blood albumin occurs in some liver 
disorders like cirrhosis, ascites. 
Total protein: This measures albumin and all other proteins in blood 
including alpha 1 antitrypsin, alpha feto protein, 
Bilirubin: This chemical gives bile its yellow/green colour. A high level of 
bilirubin in blood will make jaundiced ('yellow'). Bilirubin is made from 
haemoglobin. Haemoglobin is a chemical in red blood cells that is released 
when the red blood cells break down. Liver cells take in bilirubin and attach 
sugar molecules to it. This is then called 'conjugated' bilirubin which is 
passed into the bile ducts. 
A raised blood level of 'conjugated' bilirubin occurs in various liver and bile 
duct conditions. It is particularly high if the flow of bile is blocked. For 
example, by a gallstone stuck in the common bile duct, or by a tumour in the 
pancreas. It can also be raised with hepatitis, liver injury, or long-term 
alcohol abuse. 
A raised level of 'unconjugated' bilirubin occurs when there is excessive 
breakdown of red blood cells. For example, in haemolytic anaemia. 
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Role of Liver function tests 
 To diagnose liver disorders. 
 To monitor the activity and severity of liver disorders. 
 As a routine precaution after starting certain medicines to check that 
they are not causing liver damage as a side-effect. 
SYNTHETIC HEPATOPROTECTIVE DRUGS 
 There are no specific allopathic medicines used as hepatoprotective, 
although different research works are going on. Some drug like that 
Rimonabant chemically described as N-peperidino- 5 (4-chlorophenyl)-l-(2,4-
dichlorophenyl)-4-ethylpyrazole-3-carboxamide,isselective endocannabinoid 
(CBl) receptor antagonist, inhibits the pharmacological effects of 
cannabinoids agonists in vitro and vivo and has hepatoprotective activity 
against hepatotoxicant like ethanol. It has seen that administration of 
rimonabant at 2.5mg/kg, 5mg/kg and 10mg/kg dose level attenuated the 
increased level of the serum enzymes, produced by Ethanol and caused a 
subsequent recovery towards normalization almost like that of Silymarin 
treatment. Steroids like corticosteroids are under the study for their 
hepatoprotective action. Many other therapeutic interventions have been 
studied in alcoholic hepatitis, but have not been able to show convincing 
benefit, including trials of anti-oxidants (vitamin E, and combination anti-
oxidants), anti-fibrotics (colchicine), anti-thyroid drugs, promoters of hepatic 
regeneration (insulin and glucagon), anabolic steroids (oxandrolone and 
testosterone), as well as calcium channel blockers (amlodipine), 
polyunsaturated lecithin, and a number of complementary and alternative 
medicines.A number of other agents have been tested in patients including 
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propylthiouracil to decrease the hyper-metabolic state induced by alcohol. 
Herbal drugs are more widely used than allopathic drugs as 
hepatoprotectives because they are inexpensive, better cultural 
acceptability, better compatibility with the human body and minimal side 
effects. In other hand side effects, interactions and toxicity of synthetic 
medicines vary wildly from mild to severe include insomnia, vomiting, 
fatigue, dry mouth, diarrhea, constipation, dizziness, suicidal thoughts, 
hostility, difficulty sitting still, depression, mania, seizures, coma, anemia, 
hair loss, high blood sugar, shoplifting, swelling, impotency, panic attacks, 
confusion 
Herbal approach to treat Hepatic diseases: 
In case of hepatic disease treatment herbal drugs are widely used 
than synthetic drugs. There are various herbal plants reported as 
hepatoprotective which are as follows. 
Taraxacum officinale 
Traditionally Taraxacum officinale has been used as a remedy for 
jaundice and other disorders of the liver and gallbladder, and as a remedy 
for counteracting water retention. Generally, the roots of the plant have the 
most activity regarding the liver and gallbladder. Oral administration of 
extracts from the roots of Taraxacum officinale has been shown to act as a 
cholagogue, increasing the flow of bile. Bitter constituents like taraxecerin 
and taraxcin are active constituents of the medicinal herb. 
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Cichorium intybus 
Cichorium intybus is a popular Ayurvedic remedy for tile treatment of 
liver diseases. It is commonly known as kasni and is part of polyherbal 
formulations used in the treatment of liver diseases. In mice, liver protection 
was observed at various doses of Cichorium intybus but optimum protection 
was seen with a dose of 75 mg/kg given 30 minutes after CCl4 intoxication. 
In preclinical studies an alcoholic extract of the Cichorium intybus was as 
found, to be effective against chlorpromazine-induced hepatic damage in 
adult albino rats. A bitter glucoside, Cichorin (C32H04O19) has been 
reported to be the active constituent of the herb.  
Solanum seaforthianum 
Aromatic water extracted from the drug is widely prescribed by herbal 
vendors for liver disorders. Although clinical documentation is scare as far as 
hepatoprotective activity is concerned, but some traditional practitioners 
have reported favorable results with powdered extract of the plant. 
Glychyrrhiza glabra 
Glychyrrhiza glabra, commonly known as licorice contains triterpene 
saponin, known as glycyrrhizin, which has potential hepatotprotective 
activity. It belongs to a group of compounds known as sulfated 
polysaccharides. Several studies carried out by Japanese researchers have 
shown glycyrrhizin to be for anti-viral and it has potential for therapeutic use 
in liver disease. 
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Wilkstroemia indica 
W. indica is a Chinese herb and has been evaluated in patients 
suffering from hepatitis B. A dicoumarin, daphnoretin is the active constituent 
of the herb. The drug has shown to suppress Hbs AG in Hep3B cells. It is 
said to activator of protein kinase. 
Curcuma longa 
Like Silymarin, turmeric has been found to protect animal livers from a 
variety of hepatotoxic substances, including carbon tetrachloride, 
galactosamine, pentobarbital, I -chloro-2, 4-dinitrobenzene, 4-hydroxy-
nonenal, and paracetamol. Diarythepatonoids including Curcumin is the 
active constituent of the plant. 
Tephrosia purparea 
In Ayurveda, the plant is known as sharpunkha. Alkali preparation of 
the drug is commonly used in treatment of liver and spleen diseases. In 
animal models, it offered protective action against carbon tetrachloride and 
D-galalactosamine poisoning. The roots, leaves and seeds contain 
tephrosin, deguelin and quercetin. The hepatotprotective constituent of the 
drug is still to be proved. 
foeniculum vulgare  
 
Fennel (Foeniculum vulgare Mill. family Umbelliferae) is an annual, biennial 
or perennial aromatic herb, depending on the variety, the leaves, stalks and 
seeds (fruits) of the plant are edible. Hepatoprotective activity of Foeniculum 
vulgare essential oil was studied using a carbon tetrachloride-induced liver 
fibrosis model in rats. The hepatotoxicity produced by chronic carbon 
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tetrachloride administration was found to be inhibited by Foeniculum vulgare 
essential oil with evidence of decreased levels of serum aspartate 
aminotransferase, alanine aminotransferase, alkaline phosphatase and 
bilirubin. 
 
1.10 FREE RADICALS 
 Types of free radicals 
Free radicals can be defined as molecules containing a single 
unpaired electron in atomic or molecular orbits. These molecules are highly 
reactive ion and have an important role in the pathogenesis of tissue 
damage in various disorders such as hepatic dysfunction, mastitis, kidney 
damage, inflammation, immune injury and carcinogenesis (Abd Ellah, 2010). 
The most important free radicals include superoxide anion (O2.−), hydroxyl 
radical (.OH), and hypochlorous acid (HOCL) (Stohs, 1995). HOCL is 
produced by the reaction of hydrogenperoxide (H2O2) with chloride ions and 
plays an important role in the leukocyte respiratory burst, which is involved in 
the host defense system (Lunec, 1990). Nitric oxide (NO.) acts asa free 
radical and as a biological mediator in biochemical reactions. Physiologically 
it is synthesized from L-arginine by NO synthase employing cofactor 
NADPH. In the host, NO arises in some pathological situations, such as 
sepsis, stroke, myocardial depression, and inflammatory responses, (Bredt 
& Snyder,1994). 
Superoxide anion induces important reducing reactions in biological 
materials via Fenton like reactions, which are catalyzed by redox cycling 
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metal ions, including iron, copper, chromium and vanadium, Stohs & 
Bagchi(1995). These metal ions have the ability to acceptand donate single 
electrons, making them important catalysts of free radical reactions, themost 
widely distributed and most commonly studied transition metal ions are the 
cations iron and copper, (Stohs,1995)．Superoxide anion reduces Fe3+ in 
metalloproteins such asferritin. The reduction of protein bound iron is an 
important reaction in biological material,because if there is sufficient 
H２O２available, a reaction between the resultant Fe2+ andH２O２occurs 
and gives rise to the highly reactive .OH Lunec (1990). H２O２traverses 
biological membranes and intracellularly targets phospholipids, 
carbohydrates,metalloproteins and DNA, and causes damage via Fenton’s 
reaction, (Samuni et al,1981).The main characteristics are short living, 
unstable, react with other molecules to achieve stability. 
Sources of free radicals 
Free radicals may be released due to the by-product of cellular 
respiration, synthesized by enzyme system (phagocytic cell, neutrophils and 
macrophages),exposure to ionizing radiation, smoking, herbicides 
,pesticides, fried foods or the production by chain reaction and normal 
cellular respiration,  
Free radicals may be produced in the liver as a subsequence to 
hepatic detoxification of drugs, chemicals and toxic materials, (Feher et 
al.1992) (Ogino & Okada,1995). The formation of oxygen free radicals may 
be physiological as in phagocytosis (superoxide andH2O2 are used by 
phagocytic cells to kill bacteria), a side effect of metabolic pathways, or may 
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occur in pathological conditions due to toxic agents as in the case of 
ischemia, inflammation, disease, or due to decreased antioxidant defences. 
(Miller et al,1993). 
Mitochondria considered a major source for the production of O2.- 
and H2O2, about 2-3% of consumed oxygen is constantly converted into 
reactive oxygen/reactive nitrogen species(ROS/RNS) in the mitochondria, 
hepatocytes contain many mitochondria and therefore, generate excess 
ROS/RNS. (Stohs,1995)． 
In many liver diseases, including the wide range of neonatal hepatitis, 
the tissue inflammatory infiltrates are likely to be responsible for the 
formation of O2.-, H2O2, .OH,HOCL and the highly cytotoxic 
monochloramine. (Southorn & Powis,1988)and (McCord,1993). 
In turn, the superoxide anion attracts further neutrophils to the 
inflammatory site by a chemotactic activity, causing an increase in tissue 
injury (Petrone et al., 1980). In addition ,activated macrophages, Kupffer 
cells and vascular endothelium can generate nitric oxide,which may react 
with superoxide generating peroxynitrite. The latter is responsible for the 
inhibition of mitochondrial respiration and DNA synthesis. (Moncada & 
Higgs,1993). 
Liver damage due to iron (hemochromatosis) and copper overload is 
believed, at least partially, to derive from the catalytic activity of these metals 
in the Fenton reaction leading to the generation of ROS and increased lipid 
peroxidation with consequent abnormal mitochondrial function (Bacon et al., 
1993; Sokol et al., 1993; Sokol et al., 1994). 
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Excessive free radical production has been involved in the occurrence 
in several disease processes. 
1. drug toxicities 
2. inflammation 
3. aging 
4. fibrosis 
5. carcinogenesis 
6. lipid peroxidation cellular membranes 
7. implicated in several specific diseases 
a. atherosclerosis 
b. degenerative neurologic disease 
c. reperfusion injury 
8. oxygen toxicity 
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Sources of ROS in the liver are summarized in Fig. 3. 
 
Figure. 3. Sources of reactive oxygen species (ROS) in the liver  
(Abd Ellah et al., 2007) 
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Antioxidants 
The cells contain a variety of antioxidant mechanisms that play a 
central role in the protection against reactive oxygen species. (Pár & 
Jávor,1984) and  (Halliwell et.al 1991). The antioxidant system consists of 
antioxidant enzymes (superoxide dismutase (SOD), catalase(CAT) and 
glutathione peroxidase (GSH-Px)), glutathione, ancillary enzymes 
(glutathione reductase (GR), glutathione S-transferase, and glucose 6-
phosphate dehydrogenase (G6PD)),metal-binding proteins (transferrin, 
ceruloplasmin and albumin), vitamins (α-tocopherol,ascorbate and beta-
carotene), flavonoids, and urate (Halliwell, 1994).Pathological free radical 
reactions do not necessarily cause cell and tissue damage, asantioxidants of 
cells and tissues are able to prevent free radical injury. (Feher et al,1992). 
Onthe intracellular level, ROS formation and metabolism can be summarized 
as shown in Fig 2. 
Hepatic oxidative stress and lipid peroxidation 
The term “oxidative stress” has been coined to represent a shift 
towards the pro-oxidants in the pro-oxidant/antioxidant balance that can 
occur as a result of an increase in oxidative metabolism. Increased oxidative 
stress at the cellular level can come about as a consequence of many 
factors, including exposure to alcohol, medications, trauma, cold, infections, 
poor diet, toxins,radiation, or strenuous physical activity. Protection against 
all of these processes is dependent upon the adequacy of various 
antioxidant substances that are derived either directly or indirectly from the 
diet. 
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Consequently, an inadequate intake of antioxidant nutrients may 
compromise antioxidant potential, thus compounding overall oxidative 
stress. 
 
Figure 4-Shows different types of reactive oxygen species (ROS). 
 
Abbreviations: Glutathioneperoxidase (GSH-Px), Hypochlorous acid 
(HOCl), Hydrogen peroxide (H2O2),Myeloperoxidase (MPO), Nitric oxide 
(NO.), NO synthase (NOS), Superoxide anion (O2.-),Hydroxyl radical (.OH), 
Peroxynitrite anion (ONOO.), Superoxide dismutase (SOD),Nicotinamide 
adenine diphosphate (NADPH), Reduced glutathione (GSH), Glutathione 
reductase (GR), Glucose-6-phosphate dehydrogenase (G6PD). 
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Oxidative stress results when reactive forms of oxygen are produced 
faster than they can be safely neutralized by antioxidant mechanisms. 
(Sies,1991) and/or from a decrease in antioxidant defense, which may lead 
to damage of biological macromolecules and disruption of normal 
metabolism and physiology .(Trevisan et al,2001). This condition can 
contribute and/or lead to the onset of health disorders. (Miller et al.1993), 
and play a damaging role in a number of liver disorders, for example, in 
anoxic and re oxygenation injury during transplantation, activated 
phagocytes and xanthine oxidase formed during ischemia, catalyze the 
formation of superoxide during reperfusion (Southorn & Powis, 1988;Nauta 
et al., 1990; Brass et al., 1991; Rosser & Gores, 1995). 
 Lipid peroxidation is implicated in the pathogenesis of several hepatic 
disorders in human(Poli, 1993; Farinati et al., 1995) and animals (Mudroň et 
al., 1999; Abd Ellah et al., 2004).Hepatic failure in cattle was associated with 
decreased antioxidant mechanisms inside the cells, which led to the 
increase in the reactive oxygen species, especially H2O2. The decreasing 
hepatic GSH-Px activity in severe fatty degeneration, for example, results in 
the increaseH2O2 (Abd Ellah et al., 2004), which can initiate free radical 
formation through Fenton’sreaction. In addition, the decrease in hepatic 
vitamin E level, which is an important chain breaking antioxidant, results in 
lipid peroxidation and failure to regenerate the ascorbic acid(Mudroň et al., 
1997, 1999). Increased hepatic oxidative stress was also reported in cows 
suffering from glycogen degeneration (Abd Ellah et al., 2004), sawdust liver 
and liver abscesses (Spolarics, 1999; Abd Ellah et al., 2002; Sayed et al., 
2003). The authors contended that the antioxidant defense was high in the 
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case of sawdust liver, glycogen degeneration ,and liver abscess, which 
indicated that the body can combat the increased free radical stress. 
Liver abscesses in fattening steers occur mainly due to intensive 
feeding of highly concentrated rations. Consumption of a carbohydrate-rich 
diet stimulates G6PD expressionin endothelial and parenchymal cells (Khan 
et al., 1987; Spolarics, 1999). Since G6PDsupports reactive oxygen 
metabolism, the response may represent an antioxidant pathwayin the 
hepatic cell populations that targets sinusoid born reactive oxygen species 
duringinfections (Spolarics, 1999; Abd Ellah et al., 2002). 
ANTIOXIDANTS AND IT’S ROLE IN LIVER PROTECTION. 
The ability to utilize oxygen has provided humans with the benefit of 
metabolizing fats, proteins, and carbohydrates for energy; however, it does 
not come without cost. Oxygen is a highly reactive atom that is capable of 
becoming part of potentially damaging gmolecules commonly called “free 
radicals”. Free radicals are capable of attacking the healthy cells of the body, 
causing them to lose their structure and function. Cell damage caused by 
free radicals appears to be a major contribute to aging and to degenerative 
diseases of aging such as cancer,cardiovascular disease, cataracts, immune 
system decline, and brain dysfunction. 
Although the initial attack causes the free radical to become 
neutralized, another free radical is formed in the process, causing a chain 
reaction to occur. And until subsequent free radicals are deactivated, 
thousands of free radical reactions can occur within seconds of the initial 
reaction. Antioxidants are capable of stabilizing ,or deactivating, free radicals 
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before they attack cells. Antioxidants are absolutely critical for maintaining 
optimal cellular and systemic health and well-being. 
REACTIVE OXYGEN SPECIES 
Reactive oxygen species (ROS) is a term which encompasses all 
highly reactive, oxygen-containing molecules, including free radicals. Types 
of ROS include the hydroxyl radical, the superoxide anion radical, hydrogen 
peroxide, singlet oxygen, nitric oxide radical ,hypochlorite radical, and 
various lipid peroxides. All are capable of reacting with membrane lipids, 
nucleic acids, proteins and enzymes and other small molecules, resulting in 
cellular damage. 
ROS are generated by a number of pathways. Most of the oxidants 
produced by cells occur as: 
 A consequence of normal aerobic metabolism: approximately 90% of 
the oxygen utilized by the cell is consumed by the mitochondrial 
electron transport system. 
 Oxidative burst from phagocytes (white blood cells) as part of the 
mechanism by which bacteria and viruses are killed, and by which 
foreign proteins (antigens) are denatured. 
 Xenobiotic metabolism, i.e., detoxification of toxic substances.  
ANTIOXIDANT PROTECTION 
To protect the cells and organ systems of the body against reactive 
oxygen species, humans have evolved a highly sophisticated and complex 
antioxidant protection system. It involves a variety of components, both 
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endogenous and exogenous in origin, thatfunction interactively and 
synergistically to neutralize free radicals. 
These components include: 
 Nutrient-derived antioxidants like ascorbic acid (vitamin C), 
tocopherols and tocotrienols (vitamin E), carotenoids, and other low 
molecular weight compounds such as glutathione and lipoic acid. 
 Antioxidant enzymes, e.g., superoxide dismutase, glutathione 
peroxidase, and glutathione reductase, which catalyze free radical 
quenching reactions. 
 Metal binding proteins, such as ferritin, lactoferrin, albumin, and 
ceruloplasmin that sequester free iron and copper ions that are 
capable of catalyzing oxidative reactions. 
 Numerous other antioxidant phytonutrients present in a wide variety 
of plant foods. 
DIETARY ANTIOXIDANTS 
Vitamin C, vitamin E, and beta carotene are among the most widely 
studied dietary antioxidants. Vitamin C is considered the most important 
water-soluble antioxidant in extracellular fluids. It iscapable of neutralizing 
ROS in the aqueous phase before lipid peroxidation is initiated. Vitamin E, a 
major lipid-soluble antioxidant, is the most effective chain-breaking 
antioxidant. 
ENDOGENOUS ANTIOXIDANTS 
In addition to dietary antioxidants, the body relies on several 
endogenous defense mechanisms to help protect against freeradical-
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induced cell damage. The antioxidant enzymes – glutathioneperoxidase, 
catalase, and superoxide dismutase (SOD) – metabolizeoxidative toxic 
intermediates and require micronutrient cofactors such as selenium, iron, 
copper, zinc, and manganese for optimum catalytic activity. Intensive 
agricultural methods have also resulted in significant depletion of these 
valuable trace minerals in our soils and the foods grown in them.Glutathione, 
an important water-soluble antioxidant, is synthesized from the amino acids 
glycine, glutamate, and cystine. Glutathione directly quenches ROS such as 
lipid peroxides, and also plays a major role in xenobiotic metabolism. 
Free radicals are highly reactive substances produced continuously 
during metabolic processes. They participate mainly in physiological events 
such as the immune response, metabolism of unsaturated fatty acids, and 
inflammatory reaction. The balance between free radicals and antioxidants is 
disrupted in many diseases. This disruption may be attributedto a number of 
factors such as the inability of the cells to produce sufficient amounts of 
antioxidants, the nutritional deficiency of minerals or vitamins, and the 
excess production of reactive oxygen species. (Abd Ellah, 2010). Free 
radical excess results in impairment of DNA, enzymes, and membranes and 
induces changes in the activity of the immune system and in the structure of 
basic biopolymers which, in turn, may be related to mutagenesis and aging 
processes. (Poli, 1993).The involvement of oxidative stress in the 
pathogenesis of hepatic dysfunction in human and animals. (Khan et al, 
1987) has been investigated for many years. Some of the liver diseases 
were associated with increase (Farinati et al., 1995; Abd Ellah etal., 2002, 
2008) or decrease (Mudroň et al., 1997; Barbaro et al., 1999; Abd Ellah et 
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al., 2004) antioxidants contents. Usually hepatic antioxidants increased at 
the begining of hepatic disease and decreased in severe hepatic injury. The 
advantages of measuring hepatic oxidative status in liver are that it helps in 
diagnosis of hepatic dysfunction, reflects the degree of deterioration in the 
liver tissues, and helps to determine the severity of hepatic injury, and also, 
aid in recommending antioxidant’s therapy in patients that had a hepatic 
disease with derangement in hepatic antioxidant constituents. The main 
purpose of the current article is to explore a tool for detection of hepatic 
oxidative stress. A focus was done on different types of free radicals, 
antioxidants, lipid per oxidation, and hepatic and blood oxidative status in 
hepatic dysfunction. 
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3. AIM AND PLAN OF WORK  
AIM OF PRESENT STUDY 
In recent year there has been a tremendous increase in demand for 
herbal drugs due to its safety, efficacy and better therapeutic results and also 
due to its economic pricing as compared to synthetic or allopathic drugs, 
which have several therapeutic complications. Looking to the scope of herbal 
drugs and increasing its demand especially in disease of liver, hypertension, 
diabetes, cancer, arthritis and skin disease etc, it was planned to study 
Solanum seaforthianum in detail due its effectiveness for liver problems, 
especially for jaundice.  
Solanum seaforthianum, selected for study was made on the basis of its,  
 Easy availability 
 Folklore claiming its therapeutic use as liver protection and for 
jaundice. 
 Degree of research work which is not done. 
Very less pharmacological studies have been carried out on the 
Solanum seaforthianum. Hence, we have decided to submit the project on 
Solanum seaforthianum which includes detailed Pharmacognostical, 
Preliminary Phytochemical and Pharmacological (Acute oral toxicity study, 
Hepatoprotective activity with antioxidant effect) studies to provide scientific 
validation to its folklore claims. 
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THE PLAN OF WORK 
The plan of work for the study of Solanum seaforthianum was carried 
out as follow. 
1. Collection and authentication of plant material. 
2. Pharmacognostical studies     
                        a      Ash value 
b. Extractive value 
c.   Loss on drying 
           3. Preliminary Phytochemical studies  
a. Preparation of extract 
b. Qualitative phytochemical studies 
            4. Pharmacological studies  
a. Screening of Hepatoprotective activity, 
 Assessment of Liver Function Tests. 
 Assessment of Antioxidant parameters. 
 Histopathology of liver. 
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4. PLANT PROFILE 
 
 
 
Figure.5. Images of Solanum seaforthianum. 
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GENERAL INFORMATION: 
Common name   -   Brazilian nightshade, vining solanum potato  
    creeper, St Vincent lilac 
Binomial name  -     Solanum seaforthianum Andrews. 
Family              -      Solanaceae 
 
TAXONOMICAL CLASSIFICATION. 
Domain : Eukaryota 
Kingdom : Plantae 
Phylum : Spermatophyta 
Subphylum : Angiospermae 
Class  : Dicotyledonae 
Order  : Solanales 
Family : Solanaceae 
Genus : Solanum 
Species : Solanum seaforthianum 
 
Geographical source: 
Solanum seaforthianum  is an aquatic plant, belongs to the family 
Solanaceae, It is a floating, soloniferous herb found in ponds and streams 
almost throughout India. It is distributed in the tropical and subtropical region 
of Africa, Asia, and America.  
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Description: 
          Woody vines, twining by the petioles. Stems terete, glabrous or 
sparsely pubescent. Leaves simple or more often pinnatifid or pinnately lobed 
with up to 4 pairs of leaflets, (2-) 3.5-10(-13) x (1-)2-9(-11) cm, elliptic to 
broadly triangular in outline, widest in the basal third, membranous, the upper 
surfaces glabrous or with tiny simple uniseriate trichomes on the veins and 
margins, the lower surfaces glabrous; base acute, truncate or slightly cordate, 
occasionally oblique and asymmetric; margins less commonly entire, usually 
3-7 lobed, the lobes to 5 x 2 cm, smaller basiscopically; apex acute to 
acuminate; petioles 1-4 cm long. Inflorescences terminal, later lateral, to 25 or 
more cm long, with many open, divaricate branches, with up to 100 or more 
flowers, glabrous; pedicels 0.8-1.4 cm, Flowers all perfect, 5-merous. Buds 
globose, slightly inflated, the corolla strongly exserted from the calyx tube long 
before anthesis. Calyx tube approximately 0.5 mm, flattened and open, the 
lobes < 0.2 mm long, Corolla 1.1-2.5 cm in diameter, violet or pale violet, 
stellate-rotate, lobed ½ to 2/3 of the way to the base, the lobes 5-9 x 3-4.5 
mm, spreading or slightly cupped at an thesis, densely and minutely 
pubescent on the tips and margins; free portion of filaments markedly 
unequal, the longest filament 2-3 mm, glabrous; anthers 2-3 x 1-1.5 mm, 
occasionally one anther slightly larger, ellipsoid, loosely connivent, yellow, 
poricidal ;ovary glabrous; style 7-10 mm long, stigma capitate, minutely 
papillose. Fruit a globose berry, 0.8-1.4 cm in diameter, bright shiny red when 
ripe, glabrous, the pericarp thin; Seeds 4-20 per berry, 4-4.5 x 2.5-3 mm, 
flattened-reniform, pale yellowish tan, the surfaces minutely pitted (Knapp, 
2010). 
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Chemical constituents:  
                    Solanum seaforthianum contain alkaloids, glycosides, flavonoids, 
and steroids. An analysis of leaves and stems revealed the following: 
moisture 92.5%, protein 1.4%, fat 0.3%, carbohydrate 2.5%, fibers 0.9%, ash 
1.9%, calcium 0.2%, phosphorus 0.06%. Leaves are rich in vitamin C and A, 
and also contain vitamin B. The ash is rich in sulfate and potassium chloride. 
Stigmasta-4,22-dien-3-one, stigmasterol, stigmasteryl stearate, and palmitic 
acids are reported in P. stratiotes. Plant gave 2-di-C-glcosylflavones of vicenin 
and lucenin type, anthocyanin-cynidin-3-glucoside, luteolin-7-glycoside and 
mono-C-glcosyl flavones – vitexin and orientin. 
Habits:  
 S. seaforthianum is an ornamental vine cultivated in both tropical and 
subtropical climates in elevations ranging from sea levels to 1300 -1500 
metres (MacKee, 1994; Flora of China Editorial Committee, 2014). Once 
naturalized, the species can be found growing in natural forests, natural 
grasslands, forest margins, urban bushland, riverbanks, crops, orchards, 
pastures, roadsides, disturbed sites, and waste areas in both dry and wet 
environment. 
Medicinal uses:  
The plant is considered antitubercular, antiseptic and antidysentric. In 
Gambia, the plant is used as an anodyne for eyewash and Juice of plant is 
used by Mundas in ear complaints. The ash of the plant is applied to the 
ringworm of the scalp. Leaves are used in eczema, ulcers, piles,leprosy and 
syphilis. Juice of leaves boiled in coconut oil is applied for externally in chronic 
skin diseases. 
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COLLECTION AND IDENTIFICATION 
COLLECTION OF SPECIMEN 
The species for the proposed study that is leaves of Solanum 
seaforthianum were collected carefully from kottayam district, Kerala.  
 
TAXONOMICAL IDENTIFICATION:   
Solanum seaforthianum is grown in theponds and streams of some 
area kerala. For the present work the plant was collected from vikom, 
kottayam district of kerala .and authenticated the plant as Solanum 
seaforthianum of family Solanaceae from available literature. 
 
TREATMENT OF PLANT MATERIAL: 
The leaves Solanum seaforthianum were washed thoroughly with 
water to remove the mud or dust, then it was shade dried completely. The 
dried leaves of Solanum seaforthianum was then powdered by means of 
mixer grinder and was sieved through sieve no.60 to get the coarse powder, 
which was used for further detailed studies, extraction with solvent and 
phytochemical studies. 
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DRUG PROFILE 
CARBON TETRACHLORIDE 
      Chemical Structure: 
    
  Molecular formula:  CCl4   
  Molecular mass:  158.82 gm/mol 
  IUPAC Name:  Tetrachloromethane 
  Other names:  Benziform , Carbon Tet , Tetrazol 
  Appearance:  Colourless liquid 
  Odor: ether like odor. 
  Density: 1.5867 gm/cm3 
 Melting point: -22.92º C 
 Boiling point: 76.72º C 
 Solubility: Soluble in alcohol, ether, CHCl3 , Benzene. 
USES: 
It was widely used as a dry refrigerant, cleaning solvent, in detection of 
Neutrinos. It is one of the most potent hepatotoxins and is widely used in 
scientific research to evaluate hepatoprotective agents.  
Chapter 4  Plant Profile 
Dept. of Pharmacology 55 J.K.K.M.M.R.F. College of Pharmacy 
 
     
SILYMARIN (reference drug): 
A mixture of the isomers Silibinin, Silicrystin and Silidianin and the 
active principle from the fruit of Silybummarianum ( Carduusmarianus) 
(Compositae).The principle components are the Silibinin, silicrystin, silidianin 
and flavonolignans of which Silibinin is the major component. 
Chemical Structure of Silymarin 
 
PICTURE OF SILYMARIN: 
 
 
 
 
 
 
 
 
Figure 6: Picture of Silymarin 
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Chemical Name  : 2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl) -
2(hydroxymethyl)-6-(3,5,7-trihydroxy-4- oxobenzopyran-2-yl) benzodioxin. 
Molecular Formula  :  C25H22O10 
Molecular Weight  :  482.44 
Scientific name  :  Milk Thistle 
Other Names: Carduimariae, Mary Thistle, Holy Thistle, Lady's Thistle, Marian 
Thistle, Mariendistel, Our Lady's Thistle, Silimarina, Carduusmarianum, 
Silybin, Silybummarianum, St. Mary Thistle. , Legalon 
PROPERTIES: 
Hepato-protective: Protects liver cells from incoming toxins, thereby also 
allowing it to more effectively process and release toxins that are already built 
up in  system. 
Hepato-tonic: Strengthen the liver to function more effectively. 
Anti-depressant: By helping to move stagnant liver energy. 
Demulcent: Soothes and moistens bladder and kidneys irritations, as well as 
mucous membranes and inflammations of the skin and integumentary system. 
Laxative: Mildly lubricates the bowels. 
Hepatoprotective role of silymarin:                                                                        
Silymarin has shown differing degrees of effectiveness for protecting 
the liver from damage caused by some drugs, alcohol, chemicals, diseases, 
and poisonous plants. It is used to treat both acute conditions (such as 
poisoning) and long term diseases (such as Hepatitis C).                                                           
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Silymarin and other chemicals in milk thistle are believed to protect 
liver cells in several different ways.                                                                                               
Silymarin has antioxidant properties/free radical scavenging effect and 
has been used for the treatment of liver disorders. 
 Anti-inflammatory effects of Silymarin help in preventing hepatic cells 
from swelling after being injured.   
Silymarin seems to encourage the liver to grow new cells, while 
discouraging the formation of inactive fibrous tissue. 
 By changing the outside layer of liver cells, Silymarin actually may 
keep away certain harmful chemicals from getting into liver cells.  
Milk thistle may also cause the immune system to be more active. 
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5. MATERIALS AND METHODS 
PHARMACOGNOSTICAL STUDIES: 
 Ash values, extractive value, loss on drying are used for the study of 
physical properties. 
ANALYTICAL PARAMETERS 
ASH VALUES 
Ash values are helpful in determining the quality and purity of crude 
drug, especially in the powdered form.   
The ash content of a crude drug is generally taken to be the residue 
remaining after incineration. It usually represents the inorganic salts naturally 
occurring in the drug and adhering to it, but it may also include inorganic 
matter added for the purpose of adulteration. There is a considerable 
difference varies within narrow limits in the case of the same individual drug. 
Hence an ash determination furnishes a basis for judging the identity and 
cleanliness of a drug and gives information relative to its adulteration with 
inorganic matter. Ash standards have been established for a number of official 
drugs. Usually these standards get a maximum limit on the total ash or on the 
acid insoluble ash permitted. 
The total ash is the residue remaining after incineration. The acid 
insoluble ash is the part of the total ash which is insoluble in diluted 
hydrochloric acid. 
The ash or residue yielded by an organic chemical compound is as a 
rule, a measure of the amount of inorganic matters present as impurity. In 
most cases, the inorganic matter is present in small amounts which are 
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difficult to remove in the purification process and which are not objectionable if 
only traces are present. Ash values are helpful in determining the quality and 
purity of the crude drugs in powder form. 
Procedures given in Indian pharmacopoeia were used to determine the 
different ash values such as total ash and acid insoluble ash. 
Determination of total ash value: 
Weighed accurately about 3 gm of air dried powdered drug was taken 
in a tarred silica crucible and incinerated by gradually increasing the 
temperature to make it dull red until free from carbon cooled and weighted 
and then calculated the percentage of total ash with reference to the air dried 
drug. 
 Determination of acid insoluble ash value: 
The ash obtained as directed under total ash above was boiled with 25 
ml of 2N HCl for 5 minutes. The insoluble matter was collected on ash less 
filter paper, washed with hot water ignited and weighed, then calculated the 
percentage of acid insoluble ash with reference to the air dried drug. 
 Determination of Water soluble ash value: 
The total ash obtained was boiled with 25 ml of water for 5 minutes. 
The insoluble matter was collected on an ash less filter paper, washed with 
hot water and ignited for 15 minutes at a temperature not exceeding 450˚C. 
The weight of insoluble matter was subtracted from the weight of total ash. 
The difference in weight represents the water soluble ash. The percentage of 
water soluble ash calculated with reference to the air dried drug. 
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Determination of sulphated ash value: 
About 3 gms of accurately   weighed air dried powdered drug was 
taken in a tared silica crucible which was previously ignited and weighed. 
Then ignite gently at first until the drug was thoroughly charred. The crucible 
was cooled and residue was moistened with 1 ml of concentrated sulphuric 
acid, heated gently until the white fumes were no longer evolved and ignited 
at 800 ±  25º C until the black particles has disappeared. The crucible was 
allowed to cool, few drops of sulphuric acid was added and again heated. The 
ignition was carried out as before, allowed cooling and weighed to get a 
constant weight. The percentage of sulphated ash was calculated with 
reference to the air dried drug. All the ash values were calculated and 
recorded. 
EXTRACTIVE VALUES 
Extractive values of crude drugs are useful for their evaluation, 
especially when the constituents of a drug cannot be readily estimated by any 
other means. Further, these values indicate the nature of the constituents 
present in a crude drug. 
Determination of alcohol soluble extractive value 
5 gm of the air-dried coarse powder of Solanum seaforthianum was 
macerated with 100 ml of 90% ethanol in a closed flask for 24 hours, shaking 
frequently during the first 6 hours and allowing standing for 18hours. 
Thereafter, it was filtered rapidly taking precautions against the loss of the 
solvent. Out of that filtrate, 25 ml of the filtrate was evaporated to dryness in a 
tarred flat bottomed shallow dish, dried at 105˚C and weighed. The 
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percentage of ethanol soluble extractive value was calculated with reference 
to the air- dried drug. The results are recorded in the table. 
Determination of water soluble extractive value 
Weigh accurately 5 gm of coarsely powdered drug and macerate it with 
100 ml of chloroform water in a closed flask for 24 hours, shaking frequently 
during the first 6 hours and allow to standing for 18 hours. Thereafter, it was 
filtered rapidly taking precautions against loss of the solvent. Then 25 ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish, 
dried at 105˚C and weighed. The percentage of water soluble extractive was 
calculated with reference to the air dried drug. The results are given in the 
table. 
LOSS ON DRYING 
Loss on drying is the loss in weight in percentage w/w determined by 
means of the procedure given below. It determines the amount of volatile 
matter of any kind (including water) that can be driven off under the condition 
specified (Desiccators or hot air oven). If the sample is in the form of large 
crystals, then reduce the size by quick crushing to a powder. 
Procedure 
About 1.5 gm of powdered drug was weighed accurately in a tarred 
porcelain dish which was previously dried at 105˚C in hot air oven to constant 
weight and then weighed. From the difference in weight, the percentage loss 
of drying with reference to the air dried substance was calculated.  
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PRELIMINARY PHYTOCHEMICAL ANALYSIS 
Extraction of leaf of Solanum seaforthianum: 
 About 200 gm of air dried powdered material was taken in 1000ml 
soxhlet apparatus and extracted with petroleum ether for 2 days to remove 
fatty substances. At the end of 2nd day the powder was taken out and it was 
dried. After drying it was again packed and extracted by using methanol (S.D. 
Fine Chemicals Ltd. Mumbai, India) as solvent, till colour disappeared. After 
that extract was concentrated by distillation and solvent was recovered. The 
final solution was evaporated to dryness.  
Table: 1. Nature and colour of ethanol extract of Solanum 
seaforthianum. 
 
CHEMICAL TESTS: 
1) Test for carbohydrates 
1. Molisch Test: It consists of treating the compounds of -naphthol and 
concentrated sulphuric acid along the sides of the test tube.  
Purple colour or reddish violet colour was produced at the junction 
between two liquids. (Kokate, C.K et al, 2000) 
S.No. Name of extract Colour Consistency 
Yield% 
W/W 
1 Methanolic extract 
Dark 
greenish 
Sticky mass 12.4 
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2. Fehling’s Test: Equal quantity of Fehling’s solution A and B is added. 
Heat gently, brick red precipitate is obtained. 
3. Benedict’s test: To the 5ml of Benedict’s reagent, add 8 drops of 
solution under examination. Mix well, boiling the mixture vigorously for 
two minutes and then cool. Red precipitate is obtained. 
4. Barfoed’s test: To the 5ml of the Barfoed’s solution add 0.5ml of 
solution under examination, heat to boiling, formation of red precipitate 
of copper oxide is obtained. 
2) Test for Alkaloids 
1. Dragendroff’s Test: To the extract, add 1ml of Dragendroff’s reagent 
Orange red precipitate is produced. 
2. Wagner’s test: To the extract add Wagner reagent. Reddish brown 
precipitate is produced. 
3. Mayer’s Test: To the extract add 1ml or 2ml of Mayer’s reagent. Dull 
white precipitate is produced.    
4. Hager’s Test: To the extract add 3ml of Hager’s reagent yellow 
Precipitate is produced. 
3) Test for Steroids and Sterols 
1. Liebermann Burchard test: Dissolve the test sample in 2ml of 
chloroform in a dry test tube. Now add 10 drops of acetic anhydride 
and 2 drops of concentrated sulphuric acid. The solution becomes red, 
then blue and finally bluish green in colour. 
2. Salkowski test: Dissolve the sample of test solution in chloroform 
and add equal volume of conc. sulphuric acid. Bluish red cherry red 
Chapter 5  Materials and Methods 
 
Dept. of Pharmacology 64 J.K.K.M.M.R.F. College of Pharmacy 
 
and purple color is noted in chloroform layer, whereas acid assumes 
marked green fluorescence. 
4) Test for Glycosides 
1. Legal’s test: Sample is dissolved in pyridine; sodium nitropruside 
solution is added to it and made alkaline. Pink red colour is produced. 
2. Baljet test: To the drug sample, sodium picrate solution is added. 
Yellow to orange colour is produced. 
3. Borntrager test: Add a few ml of dilute sulphuric acid to the test 
solution. Boil, filter and extract the filtrate with ether or chloroform. 
Then organic layer is separated to which ammonia is added, pink, red 
or violet colour is produced in organic layer. 
4. Killer Killani test: Sample is dissolved in acetic acid containing trace 
of ferric chloride and transferred to the surface of concentrated 
sulphuric acid. At the junction of liquid reddish brown color is produced 
which gradually becomes blue. 
5) Test for Saponins 
Foam test: About 1ml of alcoholic sample is diluted separately with distilled 
water to 20ml, and shaken in graduated cylinder for 15 minutes.1 cm layer of 
foam indicates the presence of saponins. 
6) Test for Flavonoids 
Shinoda test: To the sample, magnesium turnings and then concentrated 
hydrochloric acid is added. Red colour is produced. 
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7) Test for Tri-terpenoids 
In the test tube, 2 or 3 granules of tin was added, and dissolved in a 2ml of 
thionyl chloride solution and test solution is added. Pink colour is produced 
which indicates the presence of triterpenoids. 
8) Tests for Tannins and Phenolic Compounds: 
The Phenol content in the raw material of Solanum seaforthianum extract was 
estimated by spectroscopically method. 
 To 2-3 ml of extract, add few drops of following reagents:  
a)  5% FeCl3 solution: deep blue-black color. 
b)  Lead acetate solution: white precipitate. 
c)  Gelatin solution: white precipitate 
d)  Bromine water: decolouration of bromine water. 
e)  Acetic acid solution: red color solution  
f)  Dilute iodine solution: transient red color. 
g)  Dilute HNO3: reddish to yellow color. 
9) Test for Fixed Oils and Fatty acids 
a). Spot test: 
 Small quantity of the extract is placed between two filter papers. Oil 
stain produced with any extract shows the presence of fixed oils and fats in 
the extracts. 
b). Saponification test: 
 Few drops of 0.5N alcoholic potassium hydroxide are added to the 
extract with few drops of phenolphthalein solution. Later the mixture is heated 
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on water bath for 1-2 hours soap formation indicates the presence of fixed oils 
and fats in the extracts. 
10) Test for Gums and Mucilage: 
a) Ruthenium red test: 
 Small quantities of extract are diluted with water and added with 
ruthenium red solution. A pink colour production shows the presence of gums 
and mucilage. 
11) Test for Proteins and Amino acids 
Biuret test: Add 1 ml of 40% sodium hydroxide and 2 drops of 1% copper 
sulphate to the extract, a violet colour indicates the presence of proteins. 
Ninhydrin test: Add 2 drops of freshly prepared 0.2% Ninhydrin    reagent to 
the extract and heat. A blue colour develops indicating the presence of 
proteins, peptides or amino acids. 
Xanthoprotein test: To the extract, add 20% of sodium hydroxide or 
ammonia. Orange colour indicates presence of aromatic amino acid. 
 
PHARMACOLOGICAL EVALUATION 
Animals: 
Healthy male Wistar albino rats of 2 to 3 months of age and 
approximately weighing between 150-250g were used in the present study. 
Rats were housed in a polypropylene cages and allowed free access to feed 
and tap water under strictly controlled pathogen free conditions with room 
temperature 25±2ºC. 
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All the animals were followed the internationally accepted ethical 
guidelines for the care of laboratory animals. The experimental protocol has 
been approved by institutional animal ethics committee, JKKMMRF College of 
Pharmacy, B.Komarapalayam, Namakkal. (Regd. No. JKKMMRFCP / 1158 / 
PO / ac / 07CPCSEA) 
EXPERIMENTAL PROTOCOL: 
The rats were divided into five groups, comprising of six animals in 
each group. 
Group – I: Received 5% CMC 10ml/kg body weight. The group served as a 
normal control. 
Group – II: Received CCl4 (0.7 ml/kg) body weight intraperitonially. 
Group - III: Received Silymarin, the standard drug (25mg/kg). 
Group – IV: Received methanolic extract of leaves of Solanum seaforthianum 
100mg/Kg. 
Group – V: Received methanolic extract of leaves of Solanum seaforthianum 
200mg/Kg. 
0.7 ml/kg of CCl4 was injected intra peritoneally (i.p.) to all groups 
except normal control to induce hepatotoxicity on 3, 6 and 10thdays of 
experiment. Duration of the study was 10 days. All the animals were sacrificed 
on the 11th day for the estimation of biochemical parameters. (Prakash 
yoganandam.G. et.al.2009). 
Estimation of serum biochemical parameters: 
On 11th day blood was collected from animals under anaesthesia by 
cardiac puncture.  Blood samples collected was centrifuged at 3500 rpm for 
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15 mins at room temperature for separation of serum. The clear, non-
haemolysed sera was separated using clean dry disposable plastic syringe 
and stored at -20ºC for measurements of the following, 
 
Liver function test: 
 Serum glutamic pyruvic transaminase (SGPT)  
 Serum glutamic oxaloacetic transaminase (SGOT)  
 Alkaline phosphatase (ALP)  
 Total protein (TP) 
 Total bilirubin (TB)  
 
Lipid profiles: 
 Cholesterol 
 Triglycerides (TG) 
 High Density Lipoprotein (HDL) 
 Low Density Lipoprotein (LDL) and  
 Very Low Density Lipoprotein (VLDL) 
 
EVALUATION OF SERUM PARAMETERS: 
All the above biochemical parameters were estimated using serum. All 
the above biochemical parameters were estimated using semi-auto analyzer 
(Photometer 5010 v5+, Germany) with enzymatic kits procured from Primal 
Healthcare limited, Lab Diagnostic Division, and Mumbai, India. 
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1) ESTIMATION OF SGPT 
Serum Glutamate Pyruvate Transaminase (SGPT)  
Principle 
L-Alanine +2-oxoglutarate            ALAT              L-Glutamate + Pyruvate  
Pyruvate + NADH + H+                                        D-Lactate + NAD+ 
Addition of pyridoxal-5-phosphate (P-5-P) stabilizes the transaminases 
and avoids falsely low values in samples containing insufficient endogenous 
P-5-P, eg., from patients with myocardial infarction, liver diseases and 
intensive care patients. 
Method 
Kinetic UV test, according to the international federation of clinical 
chemistry and laboratory medicine (IFCC) 
Table 2: Shows reagents of SGPT in the kit 
 
Reagent-1 Concentration 
TRIS PH 7.5 100 mmol/l 
L-Alanine 500 mmol/l 
LDH (lactate 
dehydrogenase) 
= 1200 U/l 
Reagent-2 Concentration 
2-Oxoglutarate 15 mmol/l 
NADH 0.18 mmol/l 
Good's buffer PH 9.6 0.7mmol/l 
Pyridoxal -5-Phosphate 0.09 mmol/l 
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Assay procedure 
Mix 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube 
a) To this, added 100 µlof serum. 
b) Mixed well and took the reading immediately. Normal range: <41 u/l 
 
2) ESTIMATION OF SGOT 
Serum Glutamate Oxaloacetate Transaminase (SGOT)  
Principle 
Alanine aminotransferase (ALAT) and aspartate amino transferase 
(ASAT) are the most important of a group of enzymes of aminotransferase. 
These enzymes act as catalyst in conversion of a-keto acids in to amino acids 
by transfer of amino groups. 
Increased levels of ALAT is found in the hepatobiliary disease condition 
where as increased ASAT levels occur in damaged conditions of heart and 
skeletal muscles well as liver parenchyma. Parallel measurement of ALAT 
and ASAT is therefore applied to distinguish liver from heart or skeletal 
muscle damages 
The ASAT/ALAT ratio is used from differential diagnosis of liver 
diseases  
L-Aspartate + 2-Oxaloglutarate       ASAT     L-Glutamate + oxaloacetate        
Oxaloacetate + NADH + H+ MDH   D-  Malate + NAD+  
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Method 
Optimized UV- test according to IFCC (International Federation of 
Clinical Chemistry and Laboratory Medicine) 
 
Table 3: shows Reagents of SGOT in the kit 
Reagent-1 Concentration 
TRIS Ph 7.8 80 mmol/l 
L- Aspartate 240 mmol/l 
MDH(malate dehydrogenase) =600 U/l 
LDH(lactate dehydrogenase) =600 U/l 
Reagent-2 concentration 
2-Oxaloglutarate 12 mmol 
NADH 0.18 mmol 
Good buffer pH 9.6 0.7 mmol/l 
Pyridoxal-5-Phosphate 0.09 mmol/l 
 
Assay procedure 
a. Mixed 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube 
b. To this, added 100 µl of serum 
c. Mixed well and took the reading immediately 
Normal range : <37u/l 
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3) ESTIMATION OF ALKALINE PHOSPHATASE  
Principle 
Alkaline phosphatase (ALP), hydrolytic enzyme acting optimally at 
alkaline pH, exists in blood in numerous distinct forms which originate mainly 
from bone and liver 
p-Nitro phenyl phosphate +water               ALP      Phosphate + p-Nitro phenol  
Method 
Kinetic photometric test, according to the international Federation of 
clinical chemistry and laboratory Medicine (IFCC). 
 
Table 4: shows reagents of alkaline phosphatase in the kit 
Reagent 1 : Concentration 
2-Amino-2-methyl-1-propanol pH 10.4 0.35 mol/l 
Magnesium sulphate 2.0 mmol/l 
Zinc sulphate 1.0 mmol/l 
HEDTA 2.0 mmol/l 
Reagent 2 : Concentration 
p-Nitrophenylphosphate 16.0 mmol/l 
Test Procedure 
a. Take 1000 µl of reagent-1 in a5 ml test tube 
b. To this add 250pl of reagent-2 and mix well 
c. Add 20 µl of serum and mix well and take reading immediately and 
read absorbance at 405nm 
Normal range: 53-128 u/l 
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4) ESTIMATION OF TOTAL PROTEIN  
Principle 
Protein forms a coloured complex with cupric ions in alkaline medium  
Table 5: Shows reagents of total protein in the kit 
Reagent-1 Concentration 
Cupric sulphate 6 mmol/l 
Potassium iodide 15 mmol/l 
Reagent-2 Concentration 
Protein (std) 6 g/100ml 
 
Method: Biuret method  
Procedure: 
Preparation of test sample 
Take l ml of reagent-1 in a5 ml test tube 
To this add 0.02 ml of serum 
Mix well and incubate at a room temperature for 15 min and Read the test 
sample at 750 nm. Normal range: 3.2 to 4.2 g/dl 
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5) ESTIMATION OF CHOLESTEROL  
     Cholesterol was estimated by the following method. 
Table 6: Shows reagents of cholesterol in the kit 
Reagent Concentration 
Ferric chloride-acetic acid reagent 0.05% 
Cholesterol stock standard 1 mg/ml in acetic acid 
Cholesterol working standard 
40 g in ferric chloride-
acetic acid reagent 
Concentrated sulfuric acid. 3.0 ml 
 
Procedure 
0.1 ml of extract was evaporated to dryness and 5.0 ml ferric chloride- 
acetic acid reagent was added, mixed and centrifuged. To the supernatant 3.0 
ml of concentrated sulfuric acid was added and the absorbance was read 
after 20 min at 560 nm against a reagent blank. A Standard in the 
concentration range of 40-200 g was treated similarly. 
 Values were expressed as mg/dL serum. 
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6) DETERMINATION OF TRIGLYCERIDES 
Triglycerides were determined by the following method. 
Triglycerides are extracted by isopropanol, which upon saponification 
with potassium hydroxide yield glycerol and soap.  The glycerol liberated is 
treated with meta per iodate, which releases formaldehyde, formic acid and 
iodide.  The formaldehyde released reacts with acetyl acetone and ammonia 
forming yellow coloured compound, the intensity of which is measured at 
420nm. 
Table 7: Shows reagents of triglycerides in the kit 
Reagent Concentration 
Saponification reagent 0.6 ml 
Sodium meta per iodate 
reagent 
650 mg. 
Acetyl acetone reagent 0.5 ml 
Standard triolein solution 
1 g of triolein was dissolved in 
100 ml isopropanol 
 
Reagents: 
1. Isopropanol 
2. Activated aluminium oxide (Neutral)  
3. Saponification reagent – 5 g of potassium hydroxide was dissolved in 
60 ml of distilled water and 40 ml of isopropanol was added to it 
4. Sodium meta per iodate reagent - 77 g of anhydrous ammonium 
acetate was dissolved in about 700 ml of distilled water, 60 ml glacial 
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acetic acid was added to it followed by 650 mg of sodium meta 
periodate.  The mixture was diluted to 1 litre with distilled water 
5. Acetyl acetone reagent - 0.75 ml of acetyl acetone was dissolved in 60 
ml of distilled water and 40 ml of isopropanol was added to it 
6. Standard triolein solution - 1 g of triolein was dissolved in 100 ml 
isopropanol. 1 ml of stock standard was diluted to 100 ml to prepare a 
working standard 100 µg of triolein/ml. 
Procedure 
An aliquot of serum/lipid extract was evaporated to dryness.  0.1 ml of 
methanol was added followed by 4 ml of isopropanol.  0.4 g of alumina was 
added to all the tubes and shaken well for 15 min.  Centrifuged and then 2 ml 
of the supernatant was transferred to labeled tubes.  The tubes were placed in 
a water bath at 65C for 15 min for saponification after adding 0.6 ml of the 
saponification reagent followed by 0.5 ml of acetyl acetone reagent.  After 
mixing, the tubes were kept in a water bath at 65C for 1 h, the contents were 
cooled and absorbance was read at 420nm. A series of standards of 
concentrations 8-40 g triolein were treated similarly along with a blank 
containing only the reagents.  All the tubes were cooled and read at 420nm. 
The triglyceride content was expressed as mg/dL - serum   
7) ESTIMATION OF HDL-CHOLESTEROL: 
Principle: 
The common classification of lipoproteins – HDL, LDL and VLDL 
comes mainly from ultra centrifugation of serum or plasma.  HDL (specific 
gravity more than 1.063) can be separated by using polyionic substances 
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along with bivalent metal ions.  HDL is separated from other protein fractions 
by treating serum with phosphotungstic acid and magnesium chloride. HDL 
remains in solution while all other lipoprotein fractions are precipitated.  
Centrifugation separates high density lipoproteins as a clear supernatant. 
Cholesterol content of which is estimated by enzymatic method as described 
earlier in estimation of total cholesterol. 
Reagents: 
1. Enzyme reagent 
2. Diluent buffer 
3. Precipitating reagent PEG-6000 
4. Standard – 200 mg/dL 
The working reagent is prepared by dissolving enzyme reagent with 
25ml of diluent buffer and kept for at least 10 min before use.  The working 
reagent is stable for 4 weeks at 2-8
0
C. 
Procedure:  
0.5 ml of serum was taken into a glass tube and added 0.05 ml of 
precipitating reagent. Mixed well, and kept at room temperature for 10 min. 
the mixture was then centrifuged for 15 min at 4000 rpm. Separated the clear 
supernatant and immediately determined cholesterol content. 
8) ESTIMATION OF LDL-CHOLESTEROL AND VLDL-CHOLESTEROL: 
The amounts of LDL-cholesterol and VLDL-cholesterol were calculated 
by using the Friedwald formula. 
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        VLDL-Cholesterol = Triglycerides / 5  
 
       LDL-Cholesterol    = Total-Cholesterol – (HDL + VLDL) 
 
The levels of HDL, LDL and VLDL-cholesterol are expressed as mg/dL. 
Estimation of antioxidant parameters: 
On 11th day animals were sacrificed after blood withdrawal and 
abdomen was cut open and liver was dissected out. 
The liver was perfused with 0.86% cold saline to completely remove all 
the red blood cells. Then it was suspended in 10% (w/v) ice-cold 0.1 M 
phosphate buffer  (pH 7.4) cut into small pieces, and the required quantity 
was weighed and homogenized using a homogenizer. The homogenate was 
centrifuged at 3000 rpm for 20 min to remove the cell debris. The supernatant 
was used for the estimation of Catalase, Superoxide dismutase, Glutathione 
peroxidase and Lipid peroxidase. 
 
INVIVO ANTIOXIDANT ENZYME ESTIMATION 
The homogenate was centrifuged and supernatant was used for the 
assay of marker enzymes namely, 
Catalase (CAT) 
Superoxide dismutase (SOD) 
Lipid peroxidation (LPO) 
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1. ESTIMATION OF CATALASE (CAT) ACTIVITY  
Reagents: 
Dichromate/acetic acid reagent (5% solution of potassium dichromate in 
acetic acid at 1:3 ratios) 
0.01 M Phosphate buffer, pH 7.0 
0.2 M Hydrogen peroxide 
Procedure: 
 Catalase(CAT) was estimated by the method of Sinha (1972).The 
reaction mixture (1.5ml vol) contained 1.0 ml of 0.01 M phosphate buffer 
(Ph7.0) 0.1 ml of tissue homogenate and 0.4 ml of 2M H202. The reaction 
was stopped by the addition of 2.0 ml dichromate-acetic acid reagent (5% 
potassium dichromate and glacial acetic acid were mixed in 1:3 ratio).Then 
the absorbance was measured at 530 nm;  
 
2. ESTIMATION OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY 
Reagents 
1. Adrenaline 
2. Carbonate buffer (pH 10.2) 
3. Mm EDTA 
Procedure: 
The activity of superoxide dismutase (SOD) was assayed by the 
method of Kakkar et al based on the oxidation of epinephrine adrenochrome 
transition by enzyme. The post-mitochondrial suspension of mice liver (0.5ml) 
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was diluted with distilled water (0.5).To this chilled ethanol (0.25ml) and 
chloroform (0.15ml) was added. The mixture was shaken for 1 min and 
centrifuged at 2000 × g for 10 min. The PMS (0.5ml) was added with PBS 
buffer (Ph 7.2; 1.5ml).The reaction initiated by the addition of 
epinephrine(0.4ml) and change in optical density (O.D.,min-l) was measured 
at 470 nm.SOD activity was expressed as U/l of tissue. Change in O.D (min-
1) at 50% inhibition to adrenochrome transition by the enzyme was taken as 
one enzyme unit. 
3. ESTIMATION OF LIPID PEROXIDATION OF RAT LIVER: 
Reagents 
1. Thiobarbituric acid 0.37% 
2. 0.25 NHC1 
3. 15% TCA 
 Procedure: 
Lipid peroxidation in liver was estimated calorimetrically by measuring 
thiobarbituric acid reactive substances (TBARS) using the method of Fraga et 
al. (1988). In brief, o.l ml of tissue homogenate was treated with 2 ml of TBA- 
trichloroacetic acid -HC1 reagent (0.37% TBA, 0.25 M HC1 and 15% TCA, 
1:1:1 ratio), placed for 15 min in a water bath and then cooled and centrifuged 
at 3500 × g for 10 min at room temperature, the absorbance of clear 
supernatant was measured at 535 nm against a reference blank. Values were 
observed. 
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HISTOPATHOLOGICAL INVESTIGATIONS 
A portion of liver processed for histopathological investigations. 
Histopathological techniques 
Histopathology is the microscopical study of tissues for pathological 
alterations. This involves collection of morbid tissues from biopsy or necropsy, 
fixation, preparation of sections, staining and microscopical examination. 
Collection of materials 
Thin pieces of 3 to 5 mm, thickness are collected from tissues showing 
gross morbid changes along with normal tissue. 
Fixation 
Keeping the tissue in fixative for 24-48 hours at room temperature 
1. Serves to harden the tissues by coagulating the cell protein, 
2. Prevents autolysis.   
3. Preserves the structure of the tissue, and 
4. Prevents shrinkage: The volume of the fixative added is 10 times the 
volume of the tissues. Common Fixatives: 10% Formalin 
Haematoxylin and eosin method of staining 
Deparaffmise the section by xylol 5 to 10 minutes and remove xylol by 
absolute alcohol, then wash in tap water. Stain with haematoxylin for 3-4 
minutes and wash in tap water. Allow the sections in tap water 5-10 min and 
wash in tap water. Counter stain with 0.5% until section appears light pink (15 
to 30seconds), and then wash in tap water. Blot and dehydrate in alcohol. 
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Clear with xylol (15 to 30 seconds). Mount in Canada balsam or DPX 
Moutant. Keep slide dry and remove air bubbles. 
 
STATISTICAL ANALYSIS 
All the values of biochemical and antioxidant parameter estimations 
were expressed as mean ± standard error of mean (S.E.M) and was analyzed 
for significance by ANOVA and groups were compared by Tukey-Kramer 
multiple comparison test, using InStat v.2.02 software (GraphPad Software  
Inc.).Differences between groups (p Value) were considered significant at 
P<0.05. 
 
Chapter 6  Results & Discussion 
 
Dept. of Pharmacology 83 J.K.K.M.M.R.F. College of Pharmacy 
 
6. RESULTS AND DISCUSSION 
The fern, Solanum seaforthianum belonging to family solanaceae was 
selected for my project, on the basis of ethanobotanical information which 
reveals its uses against one of the most hazardous disease. 
Solanum seaforthianum, is commonly called as Brazilian nightshade,  
solanum potato creeper, St Vincent lilac herb found in almost throughout 
India. 
 Literature survey revealed that not much work has been done on this 
fern claiming maximum therapeutic uses. So we felt worthwhile to validate 
scientifically, the folk claim for its therapeutic activity. We have also taken its 
detailed Pharmacognostical and preliminary phytochemical investigations to 
prove its appropriate identification and rationalize its use as drug of 
therapeutic importance. 
1. PHARMACOGNOSTICAL STUDIES: 
ANALYTICAL PARAMETERS 
The analytical parameters were investigated and reported as, total ash 
value (9.1 %w/w), water soluble ash value (3.5%w/w), acid insoluble ash 
value (3.4 %w/w),, sulphated ash value (5.2 %w/w), water soluble extractive 
value (3.7 %w/w), alcohol soluble extractive value (4.5 %w/w), loss on drying 
(5.12 %w/w). The above studies were enabled to identify the plant material for 
future investigation and form an important aspect of drug studies.  
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The results were given in table. 
a. Ash values 
Table 8 
Data for ash values for powdered leaves of Solanum seaforthianum. 
S.No 
PARAMETER 
%w/w 
ASH VALUES 
1. Total Ash 9.1 
2. Water Soluble Ash 3.5 
3. Acid Insoluble Ash 3.4 
4. Sulphated Ash 5.2 
 
b. Extractive values and loss on drying 
Table 9 
Data for extractive values and loss on drying of powdered leaves of 
Solanum seaforthianum. 
 
Analytical parameter Percentage (w/w) 
Water soluble extractive 3.7 % 
Alcohol soluble extractive 4.5 % 
Loss on drying 5.12 % 
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2. PRELIMINARY PHYTOCHEMICAL STUDIES: 
 The leaves of Solanum seaforthianum were subjected for hot 
continuous extraction using methanol as solvent. The yield was found to be 
5.27% w/w. the extracts obtained were subjected to various phytochemical 
tests, to identify the active constituents, which showed the presence of, 
alkaloids, glycosides, flavonoids, and steroids, carbohydrate, fatty acids and 
proteins and phenolic compounds. The results were given in table: 3.  
                                                   
Table 10 
Results of Phytochemical analysis of powdered leaves of Solanum 
seaforthianum. 
PHYTOCONSTITUENTS ETHANOL   EXTRACT 
Alkaloids + 
Saponins - 
Glycosides + 
Carbohydrates  + 
Tannins - 
Flavanoids + 
Terpenoids + 
Steroids + 
Phenolic compounds + 
Proteins and amino acids + 
Fixed oils and fatty acids + 
Gums and mucilage - 
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3. PHARMACOLOGICAL STUDIES: 
EVALUATION OF HEPATOPROTECTIVE ACTIVITY: 
Assessment of serum biochemical parameters: 
 Methanol extract of Solanum seaforthianum possessed a good 
hepatoprotective activity on rats as shown in the table. At varying dose levels, 
(100 mg/kg and 200 mg/kg), this extract attenuated altered biochemical 
parameters produced by CCl4 was dose dependent. This extract possessed 
significant hepatoprotective activity at both 100 and 200 mg/kg dose level. 
Table 11 
Effect of Solanum seaforthianum extract on serum parameters in CCl4 
induced hepatic damage in rats 
Treatment SGOT (U/L) SGPT (U/L) ALP (U/L) 
TOTAL 
BILIRUBIN 
(mg/dl) 
TOTAL 
PROTEIN 
(mg/dl) 
GROUP I 97.00  ± 1.41 82.73 ± 1.47 142.00 ± 1.42 0.66 ± 0.01 10.06  ± 0.04 
GROUP II 238.5 ± 1.50 363.00  ± 0.89 397.70  ± 0.75 2.14  ± 0.03 6.73 ±0.08 
GROUP III 
117.56  ± 
1.86 
106.73  ± 0.98 166.00  ± 1.41 0.76 ± 0.02 9.48 ± 0.17 
GROUP IV 
204.40  ± 
1.37 
209.0  ± 1.42 215.00  ± 1.40 1.05  ± 0.04 8.41  ± 0.07 
GROUP V 
102.20  ± 
1.03 
105.06 ± 0.98 159.00  ± 1.42 0.79  ± 0.05 8.05  ± 3.51 
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Values are given as mean ± Standard error mean (S.E.M) for five groups of 
six animals each. Values are statistically significant at * p<0.05, **p<0.01, 
***p<0.001. Group II compared with group I and Groups III, IV & V were 
compared with   group II. 
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Figure 7: Effect of Solanum seaforthianum extract on serum parameters 
in CCl4 induced hepatic damage in rats 
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Figure 8:   Effect of Solanum seaforthianum extract on total protein and 
total bilirubin in CCl4 induced hepatic damage in rats 
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Assessment of Lipid profiles: 
The serum lipid profile such as total cholesterol, triglycerides, LDL & 
VLDL were elevated, and this indicated deterioration in hepatic function due to 
the damage caused by CCl4 administration.  
Whereas treatment of Solanum seaforthianum extract significantly 
declined the effect of CCl4 induced damage and it was evidenced by the 
decreased level of total cholesterol, triglycerides, LDL & VLDL and increased 
level of HDL in extract group.  
             Results were shown in table 5. 
Table 12 
Effect of Solanum seaforthianum extract on liver lipid profiles in CCl4 
induced hepatic damage in rats 
 
Treatment 
CHOLESTEROL 
(mg/dl) 
TRIGLYCERIDES 
(mg/dl) 
HDL 
(mg/dl) 
LDL 
(mg/dl) 
VLDL 
(mg/dl) 
GROUP I 72.73 ±  1.60 80.73 ± 1.47 39.00± 1.41 31.40 ± 1.51 
14.00 ± 
0.89 
GROUP II 126.50  ± 1.21 125.23  ± 0.81 13.23  ± 1.03 74.20  ± 0.51 36.56 ±1.36 
GROUP III 8372 ± 0.75 87.23 ±1.03 29.00± 0.89 45.73± 0.75 
17.56  ± 
0.51 
GROUP IV 95.00  ± 0.89 93.00 ± 0.89 25.73  ± 1.16 48.73 ± 1.32 
21.73  ± 
1.16 
GROUP V 68.23  ± 1.03 83.4  ± 1.51 51.73  ± 0.75 38.00  ±1.41 14.4  ± 1.04 
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Values are given as mean ± Standard error mean (S.E.M) for five groups of 
six animals each. Values are statistically significant at * p<0.05, **p<0.01, 
***p<0.001. Group II compared with group I and Groups III, IV & V were 
compared with   group II. 
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Figure 9 : Effect of Solanum seaforthianum extract on liver lipid profiles 
in CCl4 induced hepatic damage in rats 
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Figure 10 : Effect of Solanum seaforthianum extract on HDL, LDL, VLDL 
in CCl4 induced hepatic damage in rats 
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Assessment of antioxidant parameters: 
 The effects of extract at two dose levels (100 and 200 mg/kg, p.o.) on 
liver antioxidant enzymes in CCl4 -induced hepatic injury are shown in Table 
2. Hepatic injury induced by CCl4 caused significant increases in liver 
antioxidant enzymes such as catalase, superoxide dismutase, glutathione 
peroxidase and lipid peroxidase. Administration of MEAI at different dose 
levels shows significant dose-dependent decreases, when compared with 
diseased control animals. Results were shown in table 6. 
Table 13 
Effect of Solanum seaforthianum extract on antioxidant parameters in 
CCl4 induced hepatic damage in rats 
 
Treatment 
 
Catalase 
(U/mg  protein) 
Superoxide 
dismutase 
(U/mg protein) 
Lipid peroxidase 
(nmol/mg of protein) 
GROUP I 291.56 ± 1.36 92.40 ±1.51 4.56± 0.51 
GROUP II 237.23 ± 0.81
 
81.73± 1.16 8.40 ± 0.54 
GROUP III 287.06 ± 0.98 76.00 ± 1.26 2.73 ± 0.40 
GROUP IV 195.73 ± 0.75
 
67.06 ± 0.75 4.56 ± 0.51 
GROUP V 277.73 ± 1.16 74.24 ± 1.36 3.56 ± 0.51 
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Values are given as mean ± Standard error mean (S.E.M) for five groups of 
six animals each. Values are statistically significant at * p<0.05, **p<0.01, 
***p<0.001. Group II compared with group I and Groups III, IV & V were 
compared with   group  
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Figure 11: Effect of Solanum seaforthianum extract on Catalase and 
SOD in CCl4 induced hepatic  damage in rats 
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Figure 12: Effect of Solanum seaforthianum extract on LPO in CCl4 induced 
hepatic damage in rats 
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Group I           
     
10x Liver with normal lobular architecture                          40x Normal portal tract and hepatocytes 
 
Group II         
 
 
10x Liver showing parenchyma with fatty change              40x Perivenular region showing fatty change 
(++++) and lobular and lobular inflammation               inflammation 
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Group III         
        
10x Liver showing parenchyma with fatty change(+)       40x Perivenular region showing fatty change. 
 
Group  IV 
      
10x Liver showing parenchyma with fatty change (+++)            40x Perivenular region showing fatty change(+++)  
    and lobular inflammation                                                            and inflammtion         
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Group  V 
       
10x Liver showing parenchyma with                40x Perivenular region showing  
     fatty change(+)             fatty change(+) 
              Figure 13.  HISTOPATHOLOGY OF LIVER OF  RAT 
 
Photomicrograph of liver shows a normal hepatic cellular arrangements 
in Group 1 (a) whereas, in group II (b) showing loss of hepatic architecture 
with intense peripheral central vein necrosis, fatty changes, crowding of 
central vein. In rats treated with silymarin (c), a normal hepatic architecture 
with moderate mild degree of necrosis. Group IV and group V (d & e) reduces 
the hepatic injury score of fatty degeneration and necrosis, clearly indicating 
the protection offered by MEAI. 
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DESCRIPTION OF HISTOPATHOLOGICAL EXAMINATION 
Group -I  
Group I rat Liver tissue section shows normal lobular architecture of 
liver cells. Hepatocytes, hepatic sinusoids, portal tract, show normal size & 
Shape. The central vein and sinusoids are normal. There are no inflammation 
fatty  change 
 
Group - II  
Group II rat Liver tissue section shows extreme degeneration of hepatic 
architecture by necrosis, foci of hemorrhage, fatty changes, crowding of vein. 
The perivenular region shows extensive fatty changes with the areas of 
lobular inflammation with hepatocytes (fatty change++++,lobular inflammation 
++ ) 
 
Group -III  
Group III Liver Tissue section shows mild degree of liver necrosis. 
Hepatocytes are compact. Hepatic sinusoids appear in normal. The 
Hepatocytes are well arranged like clusters. There is no inflammation seen, 
The portal tracts are normal ( Fatty change +) 
 
Group - IV 
Group - IV Liver tissue section shows hepatocytes with fatty change. 
Hepatic sinusoids appear in normal. There are areas of lobular inflammation 
seen along with fatty changes in the perivenular region. There no fibrosis seen 
(fatty change+++,lobular inflammation +) 
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Group - V Liver (e) 
Group - IV Liver tissue section shows that hepatocytes were 
regenerative and showed no visible changes and prominent nuclei, reduced 
score of necrosis and there is no inflammation. The portal tract are normal 
and there is no fibrosis seen.(Fatty change+, No lobular inflammation ) Thus, 
confirming the safety of the extract. 
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DISCUSSION 
Liver injury due to carbon tetrachloride in rats was first reported in 1936 
and has been widely and successfully used by many investigators. Carbon 
tetrachloride is metabolized by cytochrome P 450 in endoplasmic reticulum 
and mitochondria with the formation of CC13O
-, a reactive oxidative free 
radical, which initiates lipid peroxidation and induces liver damage. 
Damage induced in liver by carbon tetrachloride is accompanied by 
increase in the activity of some serum enzymes. The study of different 
enzyme activities such as SGOT, SGPT, ALP, TOTAL BILIRUBIN, TOTAL 
PROTEIN, CHOLESTEROL, TRIGLYCERIDES, HDL, LDL and VLDL have 
been found to be of great value in the assessment of clinical and experimental 
liver damage. 
The liver is the largest organ in the vertebrate body, and is the major 
site of xenobiotic metabolism and excretion. Liver injury can be caused by 
toxic chemicals, drugs, and virus infiltration from ingestion or infection. The 
toxins absorbed from the intestinal tract gain access first to the liver resulting 
in a variety of liver ailments. Thus liver diseases remain one of the serious 
health problems (Karan et al., 1999; Chaterrjee, 2000). Carbon tetrachloride 
(CCl4) has been widely used in animal models to investigate chemical toxin- 
induced liver damage. The most remarkable pathological characteristics of 
CCl4-induced hepatotoxicity are fatty liver, cirrhosis and necrosis, which have 
been thought to result from the formation of reactive intermediates such as 
trichloromethyl free radicals  metabolized by the mixed function cytochrome 
p450 in the endoplasmic reticulum (Recknagel et al., 1989). Usually, the 
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extent of hepatic damage is assessed by the increased level of cytoplasmic 
enzymes (ALT, AST and ALP), thus leads to leakage of large quantities 
of enzymes into the blood circulation. This was associated by massive 
centrilobular necrosis, ballooning degeneration and cellular infiltration of the 
liver (Plaa and Charbonneau, 1989).  
The aim of the present study was to investigate whether the extract 
from the fern Solanum seaforthianum possesses any preventive as well as 
curative role against CCl4 induced hepatic damages. CCl4 induced hepatic 
injuries are commonly used models for the screening of hepatoprotective 
drugs and the extent of hepatic damage is assessed by the level of released 
cytoplasmic alkaline phosphatase and transaminases in circulation. It is well 
documented that CCl4 is biotransformed under the action of microsomal 
cytochrome‐P450 of liver to reactive metabolites 31, 32. These free radicals 
bind covalently to unsaturated lipid membrane, provoking a sharp increase of 
lipid peroxides followed by pathological changes such as elevated levels of 
serum marker enzymes like SGOT, SGPT and SALP, depletion of GSH, 
decreased protein synthesis, triglyceride accumulation, increased lipid 
peroxidation, destruction of ca2+ homeostasis and finally hepatocyte damage. 
This suggests that CCl4 induces liver injury by sharing a common property of 
free radical mechanism. 
Hepatocellular necrosis or membrane damage leads to very high levels 
of serum SGOT and SGPT released from liver to circulation. Among the two, 
GPT is a better index of liver injury, since SGPT catalyses the conversion of 
alanine to pyruvate and glutamate, and released in a similar manner, thus 
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liver GPT represents 90% of the total enzyme present in the body. The 
elevated levels of serum marker enzymes are indicative of cellular leakage 
and loss of functional integrity of cellular membrane and liver. ALP activities 
on the other hand are related to functioning of hepatocytes, its increase in 
serum is due to increased synthesis in the presence of increased biliary 
pressure. It is well known that toxicants like CCl4 produce sufficient injury to 
hepatic parenchyma cells to cause elevation in serum bilirubin, and in contrast 
decrease the level of total plasma protein content. 
The activity of serum lipid profile such as total cholesterol, triglycerides, 
LDL & VLDL were elevated, and this indicated deterioration in hepatic function 
due to the damage caused by CCl4 administration. Whereas treatment of 
Solanum seaforthianum extract significantly declined the effect of CCl4 
induced damage and it was evidenced by the decreased level of total 
cholesterol, triglycerides, LDL & VLDL and increased level of HDL in Solanum 
seaforthianum treated group. 
The efficacy of any hepatoprotective drug is dependent on its capacity 
of either reducing the harmful effect or restoring the normal hepatic physiology 
that has been disturbed by a hepatotoxin.  
Necrosis or membrane damage releases the enzyme in to circulation 
and hence it can be measured in serum. A high level of SGOT indicates liver 
damage, such as that caused by viral hepatitis as well as cardiac infraction 
and muscle injury. SGPT catalyses the conversion of alanine to pyruvate and 
glutamate and is released in similar manner. Therefore SGPT is more specific 
to the liver and is thus a better parameter for detecting liver injury. Elevated 
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levels of serum enzymes are indicative of cellular damage and loss of 
functional integrity of cell membrane in liver. The ability of the methanolic 
extract of leaves of Solanum seaforthianum prevent the increase in the 
activities of these enzymes is primary evidence indicative of hepatoprotective 
activity. 
IN VIVO ANTIOXIDANT ENZYMES 
The body has an effective mechanism to prevent and neutralize the 
free radical induced damage. This is accomplished by a set of endogenous 
antioxidant enzymes, such as Catalase, Glutathione peroxidase, Superoxide 
dismutase and Lipid peroxidase. When the balance between ROS production 
and antioxidant defence is lost, oxidative stress results through a series of 
events deregulates the cellular functions leading to various pathological 
conditions. Any compound, natural or synthetic, with antioxidant properties 
might contribute towards the partial or total alleviation of this type of damage. 
Catalase (CAT) is an enzymatic antioxidant widely distributed in all 
tissues and the highest activity is found in red cells and liver. Catalase is a 
heme protein, localized in the peroxisomes or the microperoxisomes. This 
enzyme catalyses the decomposition of H2O2 to water and oxygen and thus 
protecting the cell from oxidative damage by H2O2 and OH. Therefore, the 
reduction in the activity of catalase may result in a number of deleterious 
effects due to accumulation of hydrogen peroxide. In the present study, 
treatment with methanol extract of Solanum seaforthianum leaves increased 
the level of catalase significantly in dose dependent manner and protected the 
liver from CCl4 intoxication. 
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Superoxide dismutase (SOD), a metallo protein is the most sensitive 
enzyme index in liver injury and one of the most important enzyme in the 
enzymatic antioxidant defence system. It scavenges the superoxide anion to 
form hydrogen peroxide and oxygen, hence diminishing the toxic effect 
caused by this radical. In the present study, it was observed that the methanol 
extract Solanum seaforthianum leaves, significantly increased the SOD 
activity in CCl4 intoxicated rats there by diminished CCl4 induced oxidative 
damage. 
While SOD catalyzesthe conversion of superoxide free radical to less 
toxic hydrogen peroxoide, GPx catalyzes the breakdown of hydrogen 
peroxide into water and oxygen and can also directly detoxify lipid peroxides 
generated  by ROS(Castro andFreeman,2001). As SOD and GPx are easily 
inactivated by ROS or lipid peroxides, this may explain a decrease in activities 
of these two enzymes observed in liver tissue of CCl4 intoxicated  mice in our 
study. However, our results demonstrated that SOD and GPx were 
appreciably elevated by MEAI administration, suggesting that it can restore 
both enzymes and/or activate enzyme activities in CCl4-damaged liver tissue. 
Lipid peroxidation (LPO) has been postulated as being the destructive 
process in liver injury due to CCl4 administration. The excessive ROS 
generated during CCl4metabolism rapidly reacts with lipid membranes. This 
initiates lipid peroxidation chain reaction, which produces lipid peroxy radicals. 
Enhanced hepatic MDA, a major reactive aldehyde resulting from the 
peroxidation of poly unsaturated fatty acids in the cell membrane, reflects a 
casual role of lipid peroxidation in CCl4-induced liver damage. The increase in 
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malondialdehyde (MDA) levels in liver suggests enhanced lipid peroxidation 
leading to tissue damage and failure of antioxidant defense mechanisms to 
prevent formation of excessive free radicals. Treatment with methanol extract 
of Solanum seaforthianum  leaves exhibited a significant inhibitory role 
against lipid peroxidation in rats and there by diminished CCl4 induced hepatic 
membrane destruction and hepatic damage. The prevention of lipid 
peroxidation might, at least in part, be derived from the capability of Solanum 
seaforthianum Leaves to scavange ROS. 
The qualitative phytochemical analysis on the methanolic extract of 
Solanum seaforthianum shows the presence of flavonoids. (C Pan Et.al, 
2011).  
 The dominant constituents of Solanum seaforthianum the flavonoids 
and triterpenoids. Flavonoid constituent of plant possess antioxidant and 
hepatoprotective properties (Wegner T and Fintelmann V, 1999 ).  
 
Chapter 7  Summary & Conclusion 
 
Dept. of Pharmacology 103 J.K.K.M.M.R.F. College of Pharmacy 
 
7. SUMMARY AND CONCLUSION 
The present study was undertaken to determine the hepatoprotective 
and antioxidant effect of methanolic extract from leaf of Solanum 
seaforthianum 
The Pharmacognostical studies made on the powdered leaves of 
Solanum seaforthianum like ash values, extractive value, loss on drying gave 
valuable information. This will help for correct identification of the plant. 
The preliminary phytochemical investigation showed the presence of, 
alkaloids, glycosides, flavonoids, and steroids, carbohydrate, fatty acids and 
proteins and phenolic compounds.in methanol extract. 
Histopathological studies on isolated liver revealed that methanolic 
extract of Solanum seaforthianum reversed the liver damage caused by CCl4. 
The normal pattern of histology of liver was observed. 
Phytochemical screening revealed the presence of flavonoids. 
Flavonoids have been documented to possess potent antioxidant and free 
radical scavenging effect. Example; Solanum seaforthianum contain 2-di-C-
glcosylflavones of vicenin and lucenin type, anthocyanin-cynidin-3-
glucoside,luteolin-7-glycoside and mono-C-glcosyl flavones – vitexin and 
orientin 
  Based on the results obtained from the present study, it can be 
concluded methanolic extract of Solanum seaforthianum is found to be more 
potent and effective hepatoprotective and antioxidant activity. 
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